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Patient preferences have been increasingly incorporated into clinical and 
regulatory decision-making. It leads to a growing interest in advancing and applying 
methods to study preference heterogeneity. Latent class analysis (LCA) is an emerging 
technique used in stated-preference studies to segment people by preferences instead of 
observed characteristics (e.g. demographics). The objective of this dissertation is to 
examine and advance the application of LCA in stated-preference studies in the context 
of health to support medical decision-making.  
A systematic review was first conducted to document segmentation methods used 
in the health-focused stated-preference studies in current literature. It identified current 
practices and knowledge gaps. LCA is then applied to empirical stated-preference data 
generated by two most commonly used stated-preference methods identified in the 
systematic review, namely discrete choice experiment (DCE) and best-worst scaling 
(BWS). Model specifications were modified in both applications to better serve policy 
and clinical decision-making.  
Latent class logit (LCL) is the most commonly used segmentation model that has 
been applied in both DCE and BWS. However, both applications have limitations. LCL 
sometimes over-fits the DCE data and leads to too many classes that are difficult to 
incorporate in policy or clinical decision-making when there is substantial within-class 
preference heterogeneity or significant overlap between classes. Random effects are 
incorporated in LCL models as a remedy in this dissertation. With more flexible model 
specification, random effect LCL is shown not only reducing the number of classes but 
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also better capturing the complex and dispersed preference pattern among patients than 
LCL, leading to improved model fit and prediction accuracy.  
When LCL is applied to BWS data, information criteria also often fail to identify 
the best-fitted model and parsimonious segmentation results due to cross-task constant 
utility assumption in LCL. A standard LC model was used to relax the constraint in this 
dissertation. It dramatically reduced the number of classes and generated practical 
segmentation results. Given that regulatory and clinical decision-makers often prefer 
parsimonious results due to limited resources and capacity to accommodate too many 
preference types, more flexible model specifications should be used in stated-preference 
studies to generate more practical results to support decision-making.  
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Chapter 1  Introduction 
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Patients’ preferences over medical treatments are essential because only patients 
live with their medical conditions and the consequence of treatment choices. Their 
perspective can be different from the perspective of regulators and healthcare providers. 
As researchers have been increasingly studying patient preferences to inform policy and 
clinical care, most research focuses on the average preference among patient population 
(Clark et al., 2014). However, significant preference heterogeneity may exist among 
patients due to different socioeconomic background, culture, experience, believe, or 
personality. For example, low-income people are probably more concerned about the cost 
of a treatment relative to other characteristics than higher-income people. Even with the 
same socioeconomic status, two individuals may still have different preferences due to 
different experience. When there is preference heterogeneity, the policy and clinical 
decisions made based on the average preference among patients may lead to low 
satisfaction and low treatment adherence or uptake rate.  
To further illustrate, suppose we are studying the relative importance of treatment 
cost and effectiveness in a group of patients. Suppose there are two major types of 
preferences in the population. As shown in Figure 1-1, where each axis represents the 
utility for each attribute, one group of individuals (the black dots) values cost more than 
effectiveness, while the other group (the blue dots) cares about effectiveness more than 
cost. The average preference among the entire population is where the vertical and 
horizontal lines cross. If we develop and price treatment based on this average 
preference, a majority of the cost-focused group will be unwilling or unable to pay for the 
treatment, whereas most of the effectiveness-focused group will be unsatisfied with the 
effectiveness of the treatment and wiling to pay more for more effective alternatives.  
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Knowledge about patient preference heterogeneity is valuable for policy and 
clinical decision-making when there is significant heterogeneity in the population. 
Market segmentation and product differentiation based on preference heterogeneity will 
increase the overall patient utility (Smith, 1956). Using the above example, cheaper 
treatments should be provided to the cost-conscious individuals, while more effective 
alternatives, if any, should be accessible in the effectiveness-focused group even if a 
higher price is required to cover the cost. Such tailored treatment plans will improve 
treatment adherence, which leads to better health outcomes (Capoccia et al., 2016). 
Although limited resources may not allow policy-makers and clinicians to accommodate 
each individual preference, different treatments or treatment plans should be provided to 
meet the significantly distinct needs.  
1.1 Conceptual Model to Study Preference  
The conceptual model on preference in Figure 1-2 gives us some hint on how we 
can study preference heterogeneity. The model is adapted from Simonson’s conceptual 
framework on determinants of customers’ responses to customized offers (Simonson, 
2005). As preference is difficult to directly observe, it is often inferred through choices. 
When people make choices on a product (or service), they observe the attributes (or 
features) of the product and evaluate them based on their preference to determine if the 
product is attractive. If the attributes fit the decision maker’s preference, the product is 
perceived as attractive and is likely to be chosen. If the attributes do not fit the decision 
maker’s preference, the product is unlikely to be chosen. 
Evaluation of the attributes can be affected by several factors. Individuals often 
compare options within a choice set and give little considerations to those outside of the 
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choice set, especially when they do not have clear and strong preference. Choice context, 
such as the choice scenario and the options available in the choice set (i.e., what they are 
comparing with), therefore influences the assessment of each product. Presentation 
format and the number of options available in the choice set can also have a significant 
impact on responses. For example, a large number of options decrease the likelihood of 
any single option being perceived as sufficiently attractive. Presenting the options in 
different order may also lead to different responses. (Simonson, 2005)  
This dissertation focuses on analyzing preference data from stated-preference 
surveys, the methods that have been increasingly applied to valuate healthcare services 
from patients’ perspective in the past two decades (de Bekker-Grob et al, 2012; Clark et 
al, 2014). Different from revealed preference data where real-world choices are observed, 
stated-preference methods use survey to ask people to make choices under hypothetical 
scenarios. Product attributes, presentation context, and presentation format are therefore 
controlled in an experimental environment. As a result, stated-preference methods allow 
us to reveal patients’ true preference without confounding from other factors such as 
physician preference, insurance status, and treatment availability as in patients’ real-
world treatment choices. Heterogeneous choices among respondents in a stated-
preference study can then be linked to heterogeneous preferences, after controlling for 
random errors. Despite the hypothetical choices, stated-preference methods have been 
shown to be valid predictors of consumers’ actions (Louviere et al, 1981; Kocur et al, 
1982).  
Preference for medical treatments and health services can be affected by various 
factors. Some such as demographics, socioeconomic status, and disease history, can be 
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easily observed. For example, preference for diabetes medication has been shown to 
differ by age (Hauber et al, 2016), gender (Gelhorn et al, 2013), and previous experience 
with injectable diabetes medicine (von Arx et al., 2014). Other factors that influence 
preference may not be easy to measure or document. For example, the variation in 
attitudes and behaviors about diabetes management across patients has been shown to 
reflect individual’s knowledge and opinions rather than patient’s age, gender, or culture 
(Onwudiwe et al., 2011).  
Researchers traditionally use stratification to compare the preference of sub-
groups. They separate study subjects into homogeneous groups based on observed 
characteristics (e.g., demographics) and estimate either separate models or separate sets 
of coefficients for each strata (Adamowicz et al, 1997). Stratification assumes that 
preference heterogeneity can be accurately determined a priori by observed variables 
(Boxall et al, 2003), which, as shown above, often does not hold empirically (Morey and 
Greer Rossmann, 2003; Iraguen and de Dios Ortuzar, 2004). When observed and 
unobserved factors jointly influence preference, stratification on a limited number of 
observables is insufficient to explain the variation in preference. In addition, even when 
the assumption holds, preference heterogeneity can be misclassified if stratification is 
performed based on the wrong characteristics. For example, preference variation may be 
identified across levels of educational attainment, but they may in fact relate to 
differences in the respondents’ income.  
An emerging alternative to stratification is segmentation, where respondents are 
classified into groups or clusters based on the patterns of choices or preference 
(Cunningham et al, 2008; Hole, 2008). Segmentation assumes that preferences are 
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distributed discretely into like clusters. They are not simply a function of demographic 
variables, but are formed by perceptions, experience, beliefs and unobserved variables 
(Hilger and Hanemann, 2006). Segmentation is usually estimated simultaneously with the 
choice model to identify population subsets composed of like-minded individuals with 
homogeneous preference (McFadden, 1986). Since segmentation is probabilistic (i.e. 
respondents are allocated to the group that they are most likely to be a member of), 
multivariate statistics can be used to analyze what individual characteristics are in fact 
correlated with class membership, controlling for potential confounding factors. The 
following chapters in this dissertation focus on applying segmentation methods, 
especially latent class analysis, to analyze preference heterogeneity in stated-preference 
studies.  
1.2 Statistical Model to Analyze Preference 
Random utility theory (RUT) is often applied in the analysis of choice data 
(McFadden, 1974). The theory is grounded in both psychology and economics, and 
provides a rigorous and relevant approach to understand people’s preference and choices 
(Thurstone, 1927). According to the theory, the utility an individual n obtains from 
choosing an object i can be described as a function, Uni(.), of the observed attributes of 
object i, Vni, and the unobserved characteristics and disturbances, expressed as a random 
error term εni:  
  
Uni =Vni +eni      [1] 
When there are only two objects in a choice set, i and j, i  j = 1,2, the probability that i is 
chosen over j is the probability that the utility person n obtains from i is larger than the 
utility from j, that is: 
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Pni = Pr Uni >Unj( ) = Pr Vni +eni >Vnj +enj( ) = Pr enj -eni <Vni -Vnj( )   [2]  
If the error terms, εn, are independently and identically distributed (IID) and follow a 
type I extreme value distribution (also called Gumbel distribution), the difference of the 
error terms in equation [2], εnj - εni, follows a logistic distribution (McFadden, 1974), and 
Pni has a closed form: 
    
Pni =
exp Vni( )
exp Vni( )+ exp Vnj( )
    [3] 
When there are more than two options in the choice set, the probability that person n 
chooses option i, i = 1,…,J, among J alternatives is the probability that the utility person 
n obtains from i is larger than the utility from any other alternatives in the choice set, that 
is:  
Pni = Pr Uni >Unj( ) = Pr Vni +eni >Vnj +enj( ) = Pr enj -eni <Vni -Vnj( )  [4] 
for all j ≠ i and j = 1,…,J. If the error terms are IID and follow a type I extreme value 
distribution, Pni has a closed form and can be expressed as: 
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= exp Vni -Vnj( )     [6] 
Representative utility is usually specified to be linear in parameters, i.e. Vni = x 'ni b , 
where xni is a vector of attributes relating to object i and β is a vector of utility values for 
these attributes. With this specification, if we take the logarithm of equation [6] and 










÷÷ =Vni -Vnj = x 'ni b - x 'nj b = x 'ni- x 'nj( )b   [7] 
which is the conditional logit regression that has been widely used to analyze discrete 
choice data in health (Hauber et al., 2016).  
In segmentation models, we assume β follows a discrete distribution and only 
takes Q distinct values. A latent class logit model (LCL, also termed finite mixture logit 
model) is often applied to discrete choice data to perform market segmentation 
(McFadden, 1986; Swait, 1994). It consists of a measurement model estimating class-
specific preferences and a conditional structural model determining class membership 
based on choice patterns and individual characteristics. Suppose an individual n belongs 
to a market segment q, q = 1,…,Q. The measurement model for the conditional 
probability that person n in segment q chooses i among J alternatives is: 
P
ni q
= Pn i q( ) =
exp x 'ni bq( )




.   [8] 
Preference heterogeneity is captured by the segment-specific utility parameter βq.  
The structural model on the other hand assumes that membership within a market 
segment is a function of individual characteristics (e.g. demographics), Zn, and an error 
term. Again, assuming the error term is type I extreme value distributed, the probability 
that person n belongs to segment q can be specified via a multinomial link function of 
individual covariates: 
 p nq = Pn q( ) =
exp z 'ndq( )




   [9] 
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where δ’s are the structural parameters to be estimated. For model identification, one of 
the Q segments (e.g. q=Q) is typically chosen as the reference segment by setting δQ=0. 
Then δq measures change in the odds of belonging to segment q relative to the reference 
segment Q due to each one-unit change in Zn.  
Estimation of the LCL model is conducted by joining equations [8] and [9] under 
the non-differential measurement assumption. Empirically, the probability of person n in 





Õ , where yni =1 if person n chose i and zero otherwise. Since yni =0 for all non-
chosen objects and Pni|q raises to the power of zero is 1, this term is simply the probability 
of the chosen object. Respondents often make choices in a series of scenarios in stated-
preference studies. Suppose there are T choice tasks in a survey. The probability that 








Õ , assuming conditional independence (Hole, 2008). When preference 
heterogeneity is taken into consideration, the probability of a sequence of choices being 
observed from person n is:  
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Assume choices are independent among decision makers. Then the log-likelihood 
function is: 



















å    [11] 
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where β is a vector containing all parameters of the model. The estimator is the value of β 
that maximizes this function. Because it is impossible to directly solve the equations from 
the log-likelihood function, Expectation-Maximization and Newton-Raphson algorithms 
are often used to estimate the maximum likelihood solution (Huang and Bandeen-Roche, 
2004).  
 In the following chapters, I first overview how latent class analysis has been used 
to study preference heterogeneity in stated-preference studies in health. Current practice 
is summarized based on a systematic review and compared to the analytical 
recommendation to date. The LCL model is then applied to the empirical stated-
preference data generated by two most commonly used stated-preference methods 
identified in the systematic review, namely discrete choice experiment (DCE) and best-
worst scaling (BWS). I examine and improve the application by modifying model 
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Chapter 2 Using Latent Class Analysis To Model Preference 
Heterogeneity In Health: A Systematic Review 
 




Background: The preferences of patients and other stakeholders in health are 
increasingly being used to inform decision-making. Latent class analysis (LCA) is 
increasingly used to document and explore preference heterogeneity. Using LCA is both 
an art and science, yet there is little guidance or standards on applying it in health.  
Objective: We sought to document the applications of LCA in the health-focused stated-
preference literature and to inform future studies by identifying current norms in 
published applications.  
Methods: We conducted a systematic review of the MEDLINE, Embase, EconLit, Web 
of Science, and PsycINFO databases. We included stated-preference studies that used 
LCA to explore preference heterogeneity in healthcare or public health. Two reviewers 
independently evaluated titles, abstracts, and full-text articles. Key outcomes abstracted 
included segmentation methods, preference elicitation methods, number of attributes and 
levels, sample size, model selection criteria, number of classes reported, and hypotheses 
tests. Study data quality and validity was assessed with the PREFS (purpose, respondents, 
explanation, findings, significance) quality checklist. 
Results: Among the 2,560 identified titles, 99 met the inclusion criteria for the review. 
Most studies focused on the preference of patients (34.3%) and the general population 
(31.3%). Nearly 80% used discrete choice experiments. The number of attributes 
included in the studies ranged from 3 to 20, with over half of the studies having four to 
six attributes. Sample size in LCAs ranged from 47 to 2,068, with a third between 100 
and 300. Over 90% of the studies used latent class logit models for segmentation. 
Bayesian information criterion (BIC, 59.0%), Akaike information criterion (AIC, 53.8%), 
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and log-likelihood (LL, 28.2%) were commonly used for model selection, while class 
size and interpretability were also considered in some studies. About 80% of studies 
reported two to three classes. Only 30% used statistical tests to detect significant 
variation in preference between classes. Individual characteristics were included in 
segmentation model in 47.5% of the studies, while 30.3% conducted post-estimation 
analyses to examine class characteristics. 36% and 43% of studies discussed implications 
for policy or clinical practice. 
Conclusions: LCA is increasingly used to study preference heterogeneity in health and 
support decision-making. As its application in health is relatively new, there is little 
consensus on best practices. Increasing emphasis on patient preferences from regulatory 
agencies and patient-centered care in clinical settings is likely to lead to greater demand 
for methods to quantify preference heterogeneity. Guidance is needed to improve the 
quality of LCA studies in health to support policy development and clinical practice. 
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2.1 Introduction  
Wide acceptance of the principles of patient-centered care has led to an increase 
in interest in obtaining patient input on regulatory evaluations (Califf, 2017). The Food 
and Drug Administration (FDA) recently issued guidance for premarket reviews and 
approval that listed patient preference information as an important consideration for 
regulatory reviews (CDRH, 2015). The FDA recognizes heterogeneity among patients in 
risk tolerance and benefit-risk tradeoff and has expressed willingness to approve medical 
devices with a benefit-risk profile that is only acceptable to a subset of patients (CDRH, 
2015). Understanding patient preferences and preference heterogeneity can support 
patient-centered regulatory decision-making and expand access to effective treatments.  
Stated-preference methods have been increasingly employed to valuate healthcare 
services from patients’ perspective over the past two decades (de Bekker-Grob et al., 
2012; Clark et al., 2014). Stated preference methods measure utility in order to quantify 
the strength of individuals’ preferences (Bateman et al., 2002). In choice-based conjoint 
analysis (e.g., discrete choice experiments) health products or health services are 
decomposed into attributes with varying levels. Researchers can evaluate respondents’ 
choices between competing options to understand which attributes they value most. 
Less than half of stated-preference applications in health explored preference 
heterogeneity across patient subgroups despite increased use of the methods (Clark et al, 
2014). Heterogeneity has traditionally been explored by stratifying participants into 
homogeneous groups based on observed characteristics (e.g., demographics) 
(Adamowicz et al., 1997). However, stratification requires a limiting assumption that 
preference heterogeneity can be accurately determined a priori by observed variables 
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(Boxall et al., 2003), an assumption that sometimes does not hold empirically (Morey and 
Greer Rossmann, 2003; Iraguen and de Dios Ortuzar, 2004). 
Segmentation is an emerging alternative to stratification that classifies 
respondents into groups or clusters based on response patterns (Deal, 2014). 
Segmentation is estimated simultaneously with the choice model to identify subsets of 
participants with preferences that are homogeneous within groups but heterogeneous 
between groups (McFadden, 1986). Individuals’ preferences are assumed to be formed by 
perceptions, experience, beliefs and unobserved variables, rather than simply a function 
of observed variables (Hilger and Hanemann, 2006). Segmentation is probabilistic (i.e., 
respondents are allocated to the group that they are most likely to be a member of), and 
multivariate statistics can be used to describe differences in characteristics across groups. 
Few studies adequately describe the application of these statistical methods in 
preference heterogeneity in health. This review aims to document how segmentation 
methods such as latent class analysis (LCA) have been used to study preference 
heterogeneity among stated-preference studies conducted in the health field. Best 
practices and methodological gaps in current literature are identified to provide a 
methodological guide for researchers who study preference heterogeneity in health.  
2.2 Methods 
2.2.1 Search Strategy 
We performed a literature search in MEDLINE, Embase, EconLit, Web of 
Science, and PsycINFO databases. Search terms consisted of key words for stated-
preference methods, including ‘stated preference’, ‘conjoint analysis’, ‘conjoint 
analyses’, ‘discrete choice’, ‘choice experiment’, ‘best worst scaling’, ‘choice survey’, 
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and ‘contingent valuation’, as well as segmentation methods, including ‘latent class’, 
‘finite mixture’, ‘segmentation’, ‘heterogeneity’, ‘heterogeneous’, and ‘hierarchical 
bayes’. The final search was conducted on December 31st 2016 and includes all 
publications up to the end of 2016. 
2.2.2 Inclusion and Exclusion Criteria 
Papers were included if they 1) used stated-preference methods to elicit 
preference, 2) were related to healthcare or public health, 3) analyzed preference 
heterogeneity using segmentation, and 4) were published in peer-reviewed journals. 
Articles were excluded if they 1) were not written in English, 2) did not use stated-
preference methods, 3) were not related to healthcare or public health, 4) did not analyze 
preference heterogeneity using segmentation, 5) contained no original data (e.g., review, 
commentary, editorial, book chapter, or meeting abstract), or 6) were not peer-reviewed 
(e.g., working papers, dissertation, or grey literature). Articles related to food choices 
(e.g., organic food, genetically modified foods) and environmental policies (e.g., air 
quality control) were excluded. 
2.2.3 Data extraction and Analysis 
Two reviewers (MZ and WT) independently screened titles then abstracts. Titles 
and abstracts were excluded if both reviewers determined that they did not meet the 
inclusion criteria. The two reviewers then independently reviewed the full text of the 
remaining articles. Disagreements about inclusion and exclusion based on full-text 
review were determined by consensus between the two reviewers and in case of 
remaining doubt, by a third researcher (JB).  
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For each included article, the two reviewers abstracted data independently using a 
pre-defined data abstraction form. Key outcomes comprised segmentation methods, 
preference elicitation methods, number of attributes and levels, sample size, model 
selection criteria, number of classes reported, and hypotheses tests. Study topic, year, 
country of origin, study population, alternative models used in the study in addition to 
segmentation model, prediction approaches, policy relevance, and software used for 
segmentation were also abstracted. Ordinary least squares (OLS) was used to explore 
factors that were associated with the key outcomes such as the number of attributes and 
levels, sample size, and the number of classes reported. Chi-square tests and t-tests were 
used to detect significant differences between studies.  
2.3 Search Results 
Among the 2,560 identified citations, 186 articles were eligible for full-text 
review. 99 studies met our inclusion criteria and were included in the final review (Fig. 2-
1). Among the excluded articles, 31.3% did not use stated-preference methods to measure 
preference, 28.1% were not related to healthcare or public health1, 22.6% did not original 
data, and 17.2% did not use segmentation methods to explore heterogeneity.  
[FIGURE 2-1 INSERT HERE] 
2.3.1 Trend in Time and Geographic Location 
Fig. 2-2 shows the number of studies by year. The earliest stated-preference study 
that used segmentation methods to explore preference heterogeneity in the health field 
was published in 1996. Only four studies were published between 1996 and 2006. 
Segmentation became more widely used after 2011, with the number of publications 
                                                        
1 Some of these studies examined preference for food items (e.g., organic food, genetic modified food) that 
have undetermined health impacts.  
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increasing from seven in 2011 to 27 in 2016. A majority (87.9%) of the studies in our 
review were published between 2011 and 2016. 
[FIGURE 2-2 INSERT HERE] 
Researchers in the United States (US) were the first to apply segmentation 
methods in health-related stated-preference studies to study preference heterogeneity. 
Before 2012, only Canada, US and the United Kingdom used segmentation methods in 
their preference research. The application has been expanded to more countries in the 
past five years, with the number of countries increasing from three in 2012 to 12 in 2016. 
Overall, most studies were conducted in Canada (29.3%), the US (15.1%), the UK 
(12.1%), the Netherlands (11.1%), and Australia (10.1%). Studies also took place in other 
developed countries (e.g., Germany, Italy, Switzerland, France, Spain, and Singapore) 
and some developing countries (e.g., China, Ghana, South Africa, Uganda, and Malawi). 
Two studies were performed across several countries in Europe. 
2.3.2 Study Topic and Population 
The most common study topic was preference for medical treatments (40.4%), 
followed by preference for prevention programs of physical (e.g., obesity, injury) or 
mental illnesses (e.g., depression) (22.2%). Three studies concerned preferences for 
screening tests. The most common disease categories include mental illnesses (11), 
cardiovascular diseases (5), and cancer (5). Twelve studies (12.1%) evaluated the value 
of primary, personalized, or patient-centered health services in general, and eight (8.1%) 
assessed quality of life rather than focusing on a specific disease. In addition to 
healthcare, studies also touched on job and training preferences among health care 
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providers or medical students (7), health care resource allocation (5), and the preference 
of organ donation policies (1). 
A majority of the studies were conducted among patients (34.3%), the general 
population (31.3%), and informal caregivers such as parents (18.2%). Only 12 studies 
evaluated clinicians’ preference, while some investigated the preference of other health 
services providers (2), clinic staff (2), and pharmacists (1). Two studies elicited 
policymakers’ opinions about health care resource allocation. Three articles surveyed 
medical or nursing students for job and training preferences. Research was also 
conducted among educators (2) and students (3) to evaluate school-based prevention 
programs.  
Eleven studies surveyed more than one population. Patients were included in nine, 
and their preferences were compared to the caregivers (6), clinicians (4), or the general 
population without the health condition (1). Two papers surveyed three study populations 
(i.e., patients, caregivers, and clinicians) in one study.  
One-third of the studies restricted respondents to adults (i.e., >18 years old). Five 
articles assessed preferences among children, with age range between 9 and 17 years old, 
and three articles evaluated preferences among seniors (i.e., ≥ 65 years old). Most 
(61.6%) of the studies did not have any age restrictions. 
2.3.3 Preference Elicitation Methods 
Majority of the studies (78.8%) used discrete choice experiment (DCE) to elicit 
preferences. Seventeen studies employed best-worst scaling (BWS). Segmentation of 
BWS data was first conducted in 2010 and has been increasing since 2015. Compared to 
DCE, segmentation of BWS data was less common in terms of the total number of 
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applications and geographic locations (16 countries for DCE vs. 7 countries for BWS). 
Four articles used rating to evaluate the value of health service profiles or treatment 
outcomes. 
The number of attributes included in the studies ranged from 3 to 20, with a mean 
of 7.8 and a median of 6. (Fig. 2-3) Over half of the studies (56.6%) had four to six 
attributes. A majority of the studies with 10 or more attributes were conducted in Canada 
(16) or the US (6). When there were more than 10 attributes, choice tasks often only 
included a subset of attributes to reduce respondent burden and respondents were 
randomly assigned to answer one version of choice tasks. The number of attribute in 
BWS studies ranged from 5 to 16.  
   [FIGURE 2-3 INSERT HERE] 
A linear regression (Table 2-1) showed that on average, studies conducted in 
Canada had 3.1 more attributes than those from the US (p = 0.025), holding study 
population, age group, and stated-preference methods constant. Surveys among patients 
and general population included 2.5 (p = 0.013) and 3.3 (p = 0.004) fewer attributes, 
respectively, compared to the rest, probably to reduce respondent burden. There was no 
difference in the number of attributes between different age groups or different stated-
preference methods (p > 0.05). No significant time trend was found regarding the number 
of attributes included in the studies (p = 0.101).   
[TABLE 2-1 INSERT HERE] 
The number of levels ranged from one to eight. Most (82.8%) of the studies had 
no more than four levels for each attribute. A multivariate analysis suggested that the 
maximum number of levels included in a study was not correlated with the number of 
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attributes or study population, but varied geographically and between different stated-
preference methods (Table 2-1). Studies from Canada and the UK had 1.3 (p = 0.001) and 
0.9 (p = 0.051) more levels, respectively, than those from the US. BWS had 0.7 fewer 
levels on average than DCEs (p = 0.033) because BWS object case or case 1 only allows 
one level for each attribute. Nearly half of the studies (51.0%) had unbalanced numbers 
of levels. A logistic regression showed that one additional attribute in a study was 
associated with a 4.5% increase in probability of having balanced design (p = 0.005), for 
a given stated-preference method, study population, and country of origin. This may 
suggest that researchers try to simplify study design when the number of attributes is 
larger. 
2.3.4 Sample Size 
Overall, sample size per study population ranged from 19 to 2,068, with a mean 
of 479 and a median of 290. Sample size in LCAs was relatively larger, ranging from 47 
to 2,068, with a mean of 497 and a median of 303, because several studies merged choice 
data from several study populations (e.g., patients and caregivers) in the segmentation 
analysis when one group was too small (Fig. 2-4). One-third of LCAs had sample sizes 
between 100 and 300, while fewer LCAs were performed on a sample below 100 (12.8%) 
or above 1,000 (22.9%).   
[FIGURE 2-4 INSERT HERE] 
No time trend was found regarding sample size in LCAs (p = 0.133). A 
multivariate analysis indicated that sample size was associated with the number of 
attributes, country of origin, and study population (Table 2-2). One additional attribute 
was correlated with an average of 58 more respondents (p < 0.001). Sample sizes from 
 26 
the US were relatively smaller than other regions, but only those from Australia were 
significantly higher (by 548) (p = 0.014). Surveys among the general population had 360 
more respondents on average than those among patients, providers, or caregivers (p = 
0.008), possibly due to larger sampling pools. 
[TABLE 2-2 INSERT HERE] 
2.4 Segmentation Procedures  
Most (92.9%) studies used latent class logit models for segmentation, nine of 
which considered heterogeneity in scale, and one study (Deal, 2014) compared 
probabilistic LCL model to the distance-minimizing mathematical procedures such as 
clues (CLUstEring based on local Shrinking) and pamk (Partitioning Around Medoids). 
Seven studies used k-mean cluster analysis for segmentation. Studies with rating 
techniques exclusively used k-mean cluster analysis for segmentation, whereas LCL has 
only been used to analyze discrete choice data (i.e. DCE or BWS).  
2.4.1 Model Selection Criteria 
Overall, 81.8% of the articles listed the criteria they used to identify the 
appropriate number of classes. A majority of the k-mean cluster analyses did not specify 
the criteria. Among the three articles (out of seven) that listed the model selection criteria, 
they used the Ward’s method, maximized Kappa statistics, and externally validated the 
relative importance against the self-reported values to determine the number of classes. 
Researchers also considered the interpretability of the classes to decide whether to add or 
drop a class in a model. 
Most studies (84.8%) that used LCL model specified model selection criteria, 
among which 66.7% used more than one criterion to identify the number of classes. The 
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most common criteria included Bayesian information criterion (BIC, 59.0%), Akaike 
information criterion (AIC, 53.8%), and log likelihood (LL, 28.2%), with 85.9% of the 
studies using at least one of these criteria. Other information criteria such as consistent 
AIC (CAIC, 12.8%), Hannan-Quinn information criterion (HQIC, 2.6%), and AIC3 
(1.3%) were also used in some studies. Statistic indicators such as Entropy R-square, 
McFadden’s R-square (or rho-square), and Swchwarz criterion were sometimes examined 
in addition to information criteria to help determine the optimal model. Some researchers 
went beyond the statistics and considered interpretability of the classes (16.7%), segment 
size (11.5%), or the variation between classes (2.6%) while evaluating model fit. Two 
studies predicted choices in the holdout tasks using preference estimates and chose the 
best-fitted model based on the choice hit rate. One study determined the number of 
classes based on theory.  
2.4.2 Number of Classes  
Most studies (95) reported the optimal number of classes. Among studies that did 
not report the number of classes, two stated that the aggregated model fit the data better 
than segmentation model and did not report the segmentation results; one study estimated 
solutions with two to five classes without choosing the best-fitted model; and one study 
used LCA to examine attribute non-attendance and did not focus on finding the optimal 
number of classes.  
The reported number of classes ranged from two to seven, with a mean of 2.8 and 
a median of 3. 80.2% of studies reported two to three classes, with 2-class model selected 
more often than 3-class model. Only five studies reported more than four classes, with 
four studies reporting five classes and one study reporting seven classes. A scatter plot 
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between the number of classes reported in the study and sample size suggested a positive 
correlation between the two (Fig. 2-5).  
[FIGURE 2-5 INSERT HERE] 
A linear regression showed that only sample size was correlated with the number 
of classes reported. Every thousand respondents were associated with a 0.5 increase in 
the number of classes, holding other study characteristics constant (p = 0.046). The 
number of classes did not vary systematically between different numbers of attributes or 
levels, country of origin, study population, stated-preference methods, segmentation 
methods, or model selection criteria (p > 0.05) (Table 2-3). 
[TABLE 2-3 INSERT HERE] 
2.4.3 Comparison of Preferences and Characteristics 
Most (69.7%) of studies examined preference variation between classes by simply 
comparing the magnitude of preference weights or relative importance without 
conducting any statistical tests. Among the 30 articles that used statistical tests to detect 
significant differences between classes, 21 were from Canada. 15 studies (50%) used 
Wald test, which had been widely used since 2011. Other statistic tests for cross-class 
comparison of preferences included MANCOVA, ANCOVA, Dunnett’s C test, Tukey 
comparison, and t-test, which were predominantly used by researchers in Canada.  
Almost half of studies (47.5%) included respondent characteristics in the 
segmentation model to facilitate segmentation. Seven studies (14.9%) used AIC, BIC, or 
LL ratio test to determine which characteristics should be included. Twenty-eight of the 
47 studies (59.6%) identified individual characteristics associated with class membership 
based on the coefficients of the characteristic variables in the segmentation model. Chi-
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square test, ANOVA, MANOVA, and logistic regressions were used additionally in 
several studies to analyze how respondent characteristics varied between different 
classes. 
One-third of studies (30.3%) did not include individual characteristics in the 
segmentation model but conducted post-estimation analyses to examine how individual 
characteristics differ between classes. Depending on the distribution of characteristic 
variables, chi-square test (56.7%), logistic regression (40.0%), ANOVA or MANOVA 
(26.7%), t-test (6.7%), or Wilcoxon rank sum test (3.3%) was used to test the correlation 
between class membership and characteristics. Discriminant analysis and random forests 
were also conducted to analyze class characteristics.   
2.4.4 Alternative Models and Prediction 
Among 78 DCE studies, 34.6% used only segmentation models to analyze 
preference; 46.2% compared segmentation model to the aggregated conditional logit or 
multinomial logit model; and 11.5% used Hierarchical Bayes to estimate individual 
preference weights. (Fig. 2-6) Although mixed logit (MXL) has been widely used to 
analyze preference heterogeneity in recent years, only 12 studies (15.4%) compared LCA 
results to MXL models. Logit, generalized multinomial logit (GMNL), nested logit, and 
linear probability models (LPM) were also employed in some studies. Over half of the 
studies (54.9%) with alternative models statistically compared the performance between 
different models. Common criteria included LL (29.4%), AIC (27.4%), BIC (17.6%), 
McFadden’s adjusted R-square (7.8%), and the percentage of correctly predicted choices 
(5.9%).  
[FIGURE 2-6 INSERT HERE] 
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Among 17 BWS studies, 17.6% used only segmentation models to analyze 
preferences. Less than half of studies (41.2%) compared the segmentation model to the 
aggregated conditional logit or multinomial logit model. Two studies (11.8%) estimated 
individual preference weights using Hierarchical Bayes, and only one study (5.9%) 
included MXL model. (Fig. 2-6) Best-worst scores, MaxDiff, and rank-ordered logit have 
also been used to analyze BWS data. Only one study used statistical methods to compare 
performance between models. 
One-third of studies (34.3%) predicted respondent choices and market uptake 
using estimated preference weights from the segmentation model. Over half (55.9%) of 
these studies were from Canada. In terms of prediction methods, 58.8% of studies 
performed randomized first-choice simulation. 11 studies (32.4%) conducted scenario 
analyses and estimated the expected uptake of given treatment or policy based on model 
estimates. Compared to BWS studies, where only one study predicted non-complete 
choices using model estimates, a larger percentage of DCE studies (42.3%) predicted 
respondent choices using simulation.  
2.4.5 Software 
Latent Gold (LG) Choice (26.3%), Sawtooth (21.2%), and NLOGIT (20.2%) 
were the most common software for segmentation, followed by Stata (14.1%). Sawtooth 
has been used in the past two decades since segmentation models were first applied to 
health, while LG Choice, NLOGIT, and Stata started to gain popularity since 2010. Large 
variations in the choice of test statistics and model specification exist between different 
software. When testing preference heterogeneity between different classes, Sawtooth 
users tend to use statistical methods such as ANCOVA, MANCOVA, or t-test; LG 
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Choice users only used Wald test; and no statistical tests was done among Stata users. 
This is likely due to convenience. For example, Wald test statistics are always reported in 
the output in LG Choice, which is not the case in other software. In terms of examining 
respondent characteristics in each class, individual characteristics were included in the 
segmentation model in 53.8% of studies in Stata, 57.7% of studies in LG Choice, and 
81.0% of studies in NLOGIT, but none of the studies in Sawtooth. Simulations were 
more common with Sawtooth (61.9%) and LG Choice (34.6%) possibly because a more 
user-friendly option for simulation is provided.   
2.5 Study Quality and Implication  
2.5.1 PREFS Scores 
PREFS scores of the 99 studies ranged from one to five. A majority of the studies 
scored three (56.6%) or four (28.3%). Only one study scored a one and four studies 
scored a five. The overall PREFS scores increased overtime by 0.07 per year in the past 
two decades (p < 0.001). Average PREFS scores for studies in the UK and other 
European countries were significantly higher than the average in the US by 0.72 (p = 
0.011) and 0.58 (p = 0.019), respectively, while other regions were similar to the US (p > 
0.05). 
Only one study did not clearly state the research purpose in relation to 
preferences. Most of the studies (86.9%) failed to demonstrate that responders were 
similar to non-responders. Most of the studies (90.9%) clearly explained the preference 
elicitation methods by including the actual preference question presented to the 
respondents or referencing it elsewhere. Three-fourths of the studies (74.7%) excluded 
respondents from the analysis and failed to show that the excluded did not significantly 
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differ from the included. Only four studies (4.0%) did not use significance tests to assess 
preference results. 
2.5.2 Implications 
One-third of studies (36.4%) discussed the policy implications of segmentation 
results, while 43.4% used the results to inform clinical practice. Among them, nine 
articles provided both policy and clinical recommendations. Preference results were used 
to direct the design of effective prevention programs in 10.1% of studies. Nine studies 
provided methodological recommendations. LCA has been applied in clinical studies to 
understand patient preference heterogeneity and inform clinical practice over the past two 
decades, whereas the application of LCA in policy decision-making started in 2010 and 
has been increasing thereafter. No difference in stated-preference methods or the number 
of classes was found between clinical studies and policy studies (p > 0.05). 
2.6 Discussion  
This study overviews segmentation methods used in preference studies in health. 
We found that the application of LCA in health-related stated-preference studies has 
increased dramatically over the past decade in a widening range of countries. Preferences 
were assessed in a wide variety of topics, including chronic diseases, preventative health 
behaviors, and social behaviors. Preferences among patients and the general population 
were the focus of the majority of the studies, followed by the preferences of informal 
caregivers and healthcare providers. Several studies compared preference across different 
populations. A large proportion of the studies used segmentation results to support the 
development of tailored treatments, prevention programs, or direct personalized clinical 
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care to meet various needs in the past two decades. Since 2010, LCA has been 
increasingly used to inform policy. 
2.6.1 Current Practice  
As the application of LCA in health is still relatively new, there is little guidance 
or consensus on how to perform LCA. We summarized six common steps to conduct 
LCA after reviewing the articles. We found large variations in each step among the 
studies in our review (Fig. 2-7). In this section, we summarize and compare the practice 
in current literature to the evidence to date, if available, to identify knowledge gaps and 
provide guide for researchers who are interested in using segmentation methods to study 
preference heterogeneity in the health context.  
[FIGURE 2-7 INSERT HERE] 
Step 1: Choose segmentation methods. The choice of segmentation method 
depends on the preference elicitation method used in the study. While all rating studies 
segmented respondents with distance-minimizing procedures such as k-mean cluster 
analysis, clues, and pamk, choice-based conjoint analyses (e.g., DCE and BWS) 
predominantly used LCL models. Among the latter, only 10% of the studies adjusted for 
scales, although failing to account for heterogeneity in variance (i.e. scales) in these LCL 
models has been shown to lead to biased estimates and predictions (Magidson and 
Vermunt, 2007).  
Step 2: Select optimal number of classes. LCA involves comparing segmentation 
models with various pre-specified numbers of classes to identify the appropriate number 
of classes based on model fit. Common criteria for model selection in k-mean cluster 
analyses include Ward’s method and the maximized Kappa statistic. Researchers can also 
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consider class interpretability and use respondents’ self-reported values for individual 
attributes to validate the results. 
A wide range of information criteria, as well as statistics such as LL, Entropy R-
squared, and McFadden’s R-squared, have been used to select the best-fitted LCL 
models. Although BIC has been shown to have better performance than other information 
criteria such as AIC (Nylund et al., 2007), only half of the studies used it for model 
selection. As the information criteria and other statistics only evaluate statistical 
performance of the model, a few studies adjusted the segmentation results based on class 
size, interpretability, and variation between classes to ensure policy or clinical relevance.  
Looking across the studies, the number of classes identified was not affected by 
preference elicitation methods, the number of attributes and levels included in the survey, 
segmentation methods, or model selection criteria. However, larger sample size leads to 
more classes. This could be because increasing the number of respondents introduces 
greater preference heterogeneity, or because larger sample sizes have more statistical 
power to detect preference variation. Given that half of the studies had fewer than 300 
respondents, sample size could be the reason why 80% of studies in this review reported 
two or three classes and that we did not find any differences in the number of preference 
types between different populations (e.g., patients, caregivers) and age groups.   
Step 3: Compare LCA to alternative models. LCA assumes that preferences are 
distributed discretely into like clusters (segments) (McFadden, 1986; Swait, 1994), which 
may not always be true. Researchers should therefore check this assumption by testing 
the existence of distinct clusters in the data and comparing LC model to alternative model 
specifications to detect the underlying distribution of preferences. Two-thirds of studies 
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in this review included alternative models in their analyses, but only half (or 7% among 
BWS) statistically compared the performance of different models. Moreover, while many 
studies compared the segmentation model to the aggregated model to check the existence 
of distinct classes, only a small number of studies tested for alternative preference 
distribution assumptions. Comparison between alternative models should be encouraged 
because misspecification of preference distribution may lead to biased results. However, 
an increasing use of Hierarchical Bayes to estimate individual preference weights reduces 
reliance on distribution assumptions. 
Step 4: Compare preferences between classes. If the discrete-distribution 
assumption holds, preference heterogeneity between classes should be tested statistically 
because variation in the magnitude of preference estimates may not be significant, 
depending on class size and estimate standard errors. In addition, a test of parameters 
between classes may also shed light on the distribution of preference estimates. Only 
30% of studies in this review compared preference between classes statistically, possibly 
because studies with small sample sizes were underpowered to detect heterogeneity 
between classes (i.e., there were large standard errors in some classes). It could also be 
influence by the type of software used for analyses. For example, Wald tests for equal 
preference estimates across classes were performed more by LG Choice users where 
these estimates are included in the output of LCA. In comparison, statistical tests across 
classes are more difficult to perform in Stata, and none of the Stata users statistically 
tested cross-class preference heterogeneity. Packages should be developed to allow easy 
access to post-estimation tests in all software, and researchers should choose software 
more strategically for LCAs.  
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Step 5: Identify class characteristics. Researchers and policymakers are often 
interested in understanding class membership in order to develop interventions and 
policies that can be tailored to these groups. Including individual covariates (i.e., socio 
demographic and other relevant variables) in the segmentation model to help predict class 
membership has been shown to improve model identification, fit, and interpretation 
(Boxall and Adamowicz, 2002; Huang and Bandeen-Roche, 2004; Lanza and Rhoades, 
2011; Yang and Yang, 2007), and is therefore recommended. About half of the studies in 
the literature included covariates in the model, and some tested the impact of including 
covariates on model performance. Covariate selection was often done using backward 
selection method or based on theory. Sawtooth users should be particularly encouraged to 
include covariates in the segmentation model given that none of the Sawtooth studies 
considered covariates. 
Among studies that did not include covariates in the segmentation model, a 
majority conducted post-estimation analyses to examine class-specific characteristics 
using chi-square tests, ANOVA, MANOVA, or logistic regression. Deal (2014) showed a 
more systematic approach (i.e., random forest) to identify individual variables associated 
with class membership after model estimation, which may provide a useful guide for 
researchers. 
Step 6: Predict choices or market shares. LCL models estimate class-specific 
preference weights that determine the probabilities that each class will choose a given 
treatment or service. When individual covariates are included, LCL models also estimate 
the class membership probability for an individual. Researchers can therefore predict 
individual choices based on participant characteristics, or estimate market uptake based 
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on market socio demographic composition. Prediction allows further cost-benefit 
analyses that compare the value of the treatment or service to the cost of development 
given market uptake to support decision-making.  
Predicting individual choices is challenging when individual covariates are not 
included in the model, but market shares can be estimated based on class-specific 
preference weights and segment size or using simulation. Randomized first-choice 
simulation is the most common method used for prediction, especially among Sawtooth 
users. While one-third of studies in the literature have performed prediction, few used the 
results for cost-benefit analyses. Future research should apply segmentation results to 
policy or program development.  
The quality of LCA studies improved over time. A majority of the studies clearly 
stated the study objective in relation to preferences and described preference elicitation 
methods and procedures. However, many studies failed to explain the details of statistical 
analysis such as how the model was selected when multiple criteria led to different 
conclusions (as is the case in most LCAs), how class characteristics were compared, and 
the statistics used to test for group differences. Many studies did not justify the choice of 
sample size, model specification, model selection criteria, and covariates to include in 
model. In terms of generalizability, a majority of the studies did not provide sufficient 
evidence to show that respondents in the analysis were representative of the study 
population. As the application of LCA in health expands, researchers should continue 





There are two major limitations in this review. First, it is challenging to determine 
the boundary of public health relevance. Many topics, such as the choice of organic or 
genetically modified foods, were excluded due to undetermined health impacts. Future 
research could further examine LCAs in these fields, but the segmentation methods used 
in these studies are likely similar. Second, there could be publication bias in the literature. 
In our review, only one study stated that LCA was conducted but not reported because 
the aggregated model had better fit. It is possible that studies not included in this review 
performed segmentation but only reported results from other models (e.g., CL, MXL) due 
to better fit. Future research should be more transparent about methods used in the study. 
2.7 Conclusion 
LCA has been increasingly used to study preference heterogeneity in health. It has 
been applied in a wide range of medical conditions and health areas to support the 
development of treatments or prevention programs. However, there is little consensus and 
guidance on appropriate application. With the increasing emphasis on patient preference 
from regulatory agencies and patient-centered care in clinical settings, there will be 
higher demand to study patient preference and preference heterogeneity. More guidance 
is needed to improve the quality of LCA studies in health to meet this demand and 
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Not healthcare or public health: 549 
No segmentation: 18 
No original data: 497 




Not healthcare or public health: 132 
No segmentation: 371 
No original data: 59 




Not healthcare or public health: 15 
No segmentation: 17 
No original data: 5 
No measure of stated-preference: 9 
Unavailable: 21 
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Figure 2-2 Number of segmentation studies and discrete-choice studies by year 
 



























































Figure 2-6 Alternative models used in the studies in addition to segmentation model 
 
LCA: latent class analysis; CL: conditional logit; MNL: multinomial logit; HB: 
hierarchical bayes; MXL: mixed logit; DCE: discrete choice experiment; BWS: best-
























Figure 2-7 Six steps for segmentation analysis with preference data 
 
  
Choose Segmentation Methods 
 Distance-minimizing procedures (e.g. k-mean, clues, pamk) 
 Probabilistic models (e.g. LCL) 
Select Optimal Number of Classes 
 K-mean: Ward’s method, maximized Kappa, external validation 
 LCL: information criteria (e.g. BIC), LL, Entropy R2, McFadden’s 
adjusted R2, class size, interpretability, holdout task hit rate 
Compare Preference between Classes 
 K-mean: ANCOVA 
 LCL: Wald test, ANCOVA, MANCOVA, Dunnett’s C test, Tukey 
comparison, t-test 
Identify Class Characteristics 
 Include individual characteristics in segmentation model 
 Post-estimation analyses: random forest 
Compare LCA to Alternative Models 
 Alternative models: aggregate model, MXL, HB 
 Criteria: information criteria (e.g. BIC), LL, McFadden’s adjusted 
R2, prediction hit rate 
Predict Choices or Market Shares 
 Scenario analyses 
 Randomized first-choice simulation 
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Table 2-1 Linear regression of the number of attributes and levels on study 
characteristics 
 No. of Attributes No. of Levels 
 Coef.   (SE) Coef.   (SE) 
No. of attributes -        - -0.03 (0.04) 
Country of origin     
Australia 0.19 (1.36) 0.19 (0.48) 
Canada 3.15 (1.37)* 1.33 (0.40)** 
UK -1.20 (1.15) 0.94 (0.48)* 
Other EU -0.95 (1.15) 0.42 (0.36) 
Other -1.53 (1.08) 0.35 (0.49) 
US Reference    
Study population     
Patient -2.55 (1.01)* 0.08 (0.32) 
Clinician -0.60 (1.13) -0.07 (0.37) 
Caregiver 2.05 (1.21) -0.25 (0.24) 
General population -3.29 (1.12)** 0.78 (0.50) 
Age group     
≤18 years 0.38 (1.12) 0.09 (0.44) 
>18 years 0.79 (0.75) -0.03 (0.36) 
>65 years 0.86 (0.96) -0.28 (0.45) 
No age restriction Reference    
SP methods     
Rating 1.03 (0.87) -0.37 (0.78) 
BWS -0.07 (1.13) -0.65 (0.30)* 
DCE Reference    
* p<0.05; ** p<0.01; *** p<0.001 




Table 2-2 Linear regression of sample size on study characteristics 
 Coef.    (SE) 
No. of attributes 58.23   (11.65)*** 
No. of levels 53.40   (39.02) 
Country of origin   
Australia 547.56 (218.07)* 
Canada 195.36 (145.92) 
UK 218.95 (174.60) 
Other EU 259.63 (132.14) 
Other 75.10 (127.70) 
US Reference  
Study population   
Patient -46.36 (98.68) 
Clinician -29.91 (115.37) 
Caregiver 49.71 (102.43) 
General population 360.12 (144.26)* 
Age group   
≤18 years 242.49 (193.14) 
>18 years 140.77 (111.11) 
>65 years -207.26 (137.57) 
No age restriction Reference  
SP methods   
Rating -133.57 (189.33) 
BWS -162.67 (92.72) 
DCE Reference  
* p<0.05; ** p<0.01; *** p<0.001 




Table 2-3 Linear regression of the number of classes on study characteristics 
 Coef.   (SE) 
Sample size (in 100s) 0.05 (0.02)* 
No. of attributes -0.01 (0.03) 
No. of levels 0.04 (0.08) 
Country of origin   
Australia 0.89 (0.63) 
Canada -0.21 (0.35) 
UK -0.05 (0.38) 
Other EU 0.23 (0.44) 
Other -0.05 (0.35) 
US Reference  
Study population   
Patient -0.25 (0.29) 
Clinician 0.25 (0.34) 
Caregiver 0.17 (0.29) 
General population -0.64 (0.37) 
Age group   
≤18 years -0.51 (0.37) 
>18 years 0.12 (0.27) 
>65 years 0.72 (0.38) 
No age restriction Reference  
SP methods   
Rating -0.45 (0.89) 
BWS -0.13 (0.36) 
DCE Reference  
Segmentation methods   
LCL Reference  
Scale-adjusted LCL 0.40 (0.51) 
K-mean 0.59 (0.85) 
Model selection criteria   
AIC -0.06 (0.28) 
BIC 0.22 (0.20) 
Log-likelihood 0.45 (0.30) 
Interpretability 0.29 (0.25) 
* p<0.05; ** p<0.01; *** p<0.001 
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Chapter 3 Explore Preference Heterogeneity For The 
Treatment of People With Type 2 Diabetes: A Comparison of 
Random-Parameters And Latent-Class Estimation Techniques 
 





There has been an increasing interest in studying patient preference heterogeneity 
to support regulatory decision-making. While the traditional mixed logit (MXL) and 
latent class logit (LCL) models have been commonly used to analyze preference 
heterogeneity in discrete choice data, they have limitations. This study empirically 
compares an innovative random effect latent class logit (RELCL) model to the traditional 
approaches using preference data from a discrete-choice experiment among patients with 
type 2 diabetes. The survey contained 18 pairs of hypothetical diabetes medications that 
differed in six attributes.  
Significant preference heterogeneity was found in all models. The best-fitted 
RELCL has the lowest BIC (8350.64) and predication error (11.61%) compared to MXL 
(BIC=8587.38; pred. err.=13.02%) and the best-fitted scale-adjusted LCL (BIC=8403.18; 
pred. err.=15.69%), indicating improved model fit. Allowing random effect also reduces 
the number of classes from five in scale-adjusted LCL to two and both have significant 
policy and clinical implications. RELCL provides the flexibility of LCL and the 
parsimony of MXL. When significant within-class heterogeneity exists as in patients with 
prevalent chronic diseases, RELCL may be used to generate more accurate predictions 
and more parsimonious results that are policy-relevant.   
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3.1 Introduction 
The United States Food and Drug Administration (FDA) issued guidance in 2015 
to incorporate patient preference into their regulatory decision-making (CDRH, 2015). 
Following the issue of guidance, results from two stated-preference studies have been 
used to support the market approval of new treatments (Ho et al., 2015; Peay et al., 
2014). Since then, there has been an increasing interest in studying patient preference 
because of significant policy implication.  
One key regulatory change according to the FDA guidance is that the agency is 
willing to approve treatments even if the benefit-risk profile is only acceptable to a subset 
of risk-tolerant patients (CDRH, 2015). Studying preference heterogeneity among 
patients is therefore meaningful. The demand for studying heterogeneity requires an 
examination and comparison of different approaches to analyzing preference 
heterogeneity and guidance on choosing appropriate methods to ensure unbiased results 
to support regulatory decision-making.  
Mixed logit (MXL, also termed random parameter logit) and latent class logit 
(LCL, also termed finite mixture logit) are the most commonly used models to study 
unobserved preference heterogeneity in stated-preference literature (McFadden, 1986; 
Swait, 1994). MXL allows some or all of the preference parameters to be random and 
vary across individuals according to a continuous probability distribution (Bhat, 1998; 
Revelt and Train, 1998; Brownstone and Train, 1998). LCL assumes that preferences are 
distributed discretely into clusters (segments). Preferences are similar among individuals 
within clusters but vary between clusters (McFadden, 1986). Heterogeneity in variances 
(i.e. scales) is sometimes adjusted in addition to preference heterogeneity in a scale-
 61 
adjusted latent class logit (SLCL) model (Fiebig et al, 2010; Louviere et al, 2000). SLCL 
allows respondents in the same preference group to have different variances (i.e. scale 
parameters) that reflect the consistency of their choices compared to preference (Flynn et 
al, 2010; Magidson and Vermunt, 2007; Campbell et al, 2011).  
Many stated-preference studies in health use LCL or SLCL to analyze preference 
heterogeneity because the segmentation results have more straightforward interpretation 
than MXL. Despite weaker assumptions on the distributions of parameters, LCL often fits 
the data at least as well as MXL (Louviere, 2006). However, one limitation of LCL or 
SLCL model is that it assumes preference coefficients take only a set of distinct values 
and are homogeneous within classes, which sometimes does not hold empirically. When 
there is substantial within-class preference heterogeneity or significant overlap between 
classes, LCL often leads to too many classes (Lenk and DeSarbo, 2000). As MXL can 
accommodate more extensive heterogeneity with fewer parameters, it may not be 
sufficient when there are sizeable subgroups.  
As a remedy, Lenk and DeSarbo (2000) proposed using random effects in LCL 
models, which provides the flexibility of LCL and the parsimony of MXL. Given the 
complication and wide variation of preference in healthcare, random effect LCL 
(RELCL) may better capture the preference distribution. However, few stated-preference 
studies have tested this approach. In this paper, we sought to empirically compare 
RELCL to the traditional MXL and LCL/SLCL in analyzing unobserved preference 
heterogeneity. We also demonstrate the approaches to testing the underlying distribution 
of preferences and selecting the appropriate model to analyze preference heterogeneity 
for researchers who are interested in studying patient preference.  
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The data is from a discrete-choice experiment (DCE) survey among patients with 
type 2 diabetes on preference for diabetes medications. Preference for treatment for type 
2 diabetes is selected as a case study because diabetes is a prevalent chronic condition 
that affects nearly 30 million individuals in the US and the complications of diabetes 
result in significant morbidity and costs (CDC, 2014). While treatment options have 
expanded (Tran et al, 2015), poor adherence to known effective interventions persists. 
Understanding patient preference and incorporating it in drug development and clinical 
guidelines could therefore improve adherence, satisfaction, and quality of life, and have 
significant public health impact.  
3.2 Methods 
3.2.1 DCE survey instrument 
A robust, comprehensive, and engaged process was used to develop the survey 
(Janssen et al, 2016). The attributes in the survey included the amount of reduction in 
hemoglobin A1c, the duration of stable blood glucose levels, frequency of hypoglycemia, 
duration of nausea per day, treatment burden, and cost (Table 3-1). Each attribute had 
three levels. Information about the attributes and levels was provided to respondents 
before they answered the DCE choice tasks. The attributes and levels as well as the 
framing of the information was pretested among patients to make sure they were 
appropriate.  
[TABLE 3-1 INSERT HERE] 
A Bayesian D-efficient design generated by Ngene was used, with priors obtained 
from the pilot data. The design consisted of 48 choice tasks divided into three blocks. The 
blocks were selected to minimize the correlation between blocks and attribute levels. 
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Each block contained 16 choice tasks plus two additional holdout tasks. One holdout task 
repeated one of the 16 tasks in the block to assess test-retest reliability. The other one 
remained the same across all three blocks to test systematic difference in preference 
between blocks. Each respondent was randomly assigned to a block. Choice tasks were 
presented in random order. Each task asked respondents to choose between two 
hypothetical mediations for type 2 diabetes (Figure 3-1). The survey also asked the 
respondents’ diabetes history, current disease management, health status, health 
behaviors (e.g. smoking, exercise), and personalities measured by Likert scales.  
[FIGURE 3-1 INSERT HERE] 
3.2.2 Data collection 
A national survey was conducted among patients with type 2 diabetes through the 
GfK KnowledgePanel in 2015. It is an online panel that provides sampling coverage of 
97% of the US adult population (Couper, 2000). GfK surveys include both listed and 
unlisted numbers, and are not limited to current Internet users or computer owners. There 
has been shown to be over 4,000 potential respondents with type 2 diabetes in the panel, 
with a high proportion of complex patients (Safford et al, 2007). Due to higher 
prevalence of diabetes (CDC, 2014) and lower adherence rates to treatments (Egede et al, 
2011), African Americans and Hispanics were oversampled in this study. Hispanics had 
the option to take the survey in English or Spanish. GfK provided respondents’ socio 
demographic data and calculated sample weights to rebalance the sample to national 
norms for the assessment of aggregate results. This study has been exempt from the Johns 




3.2.3 Statistical analysis 
The DCE data was analyzed in a random utility framework (McFadden, 1974), 
where individuals are assumed to choose the option with the greatest utility. The utility 
that person n, n = 1,…,N, obtains from choosing medicine i, i = 1,2, in choice task t, t = 
1,…,16, can be written as: 
Unit = x 'it b +enit      [1] 
where x is a vector of the six attributes of medicine i, β is a vector of utility values for 
these attributes, and ε is an independently and identically distributed (iid) error term. 
When ε follows a type I extreme value distribution (also termed Gumbel distribution), the 
probability of person n choosing medicine i over j in choice task t is:  
Pn it b, xt( ) =
exp x 'it b( )
exp x 'it b( )+ exp x ' jt b( )
=
1
1+ exp x jt - xit( ) 'b
.   [2]  
The probability of individual n choosing a sequence of choices in the 16 choice tasks is 
then: 
Pn y b, x( ) = Pn it b, xt( )
t=1
16
Õ      [3] 
where y represents a vector of choices that respondent n makes in the 16 choice tasks.  
While interaction term can be added between β and individual characteristics (e.g. 
age, gender) to capture preference heterogeneity between groups, the model in equation 
[2] (i.e., conditional logit, CL) assumes no unobserved preference heterogeneity among 
respondents. The assumption that preference heterogeneity can be accurately determined 
a priori by observed variables often does not hold empirically (Morey and Greer 
Rossmann, 2003; Iraguen and de Dios Ortuzar, 2004).  
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To analyze unobserved preference heterogeneity, we first used MXL, assuming 
the preference weights (β) for all attribute levels are normally distributed across 
respondents. The preference weights of individual n are then specified as:  
bn = b +sun      [4] 
where β is a vector of mean preference weights for the attribute levels, un is multivariate 
normally distributed with correlation matrix R, and σ is a vector of standard deviations of 
the preference weights. We assumed independent preference weights for different levels 
of the same attribute and allowed them to have different variances. When σ = 0, MXL 
reduces to CL.  
MXL reports weighted average β across all respondents. Based on these 
estimates, we calculated the relative attribute importance (RAI) for each attribute by 
dividing the difference between the maximum and minimum preference weights for the 
levels within an attribute by the sum of such differences of all six attributes. RAI 
measures the relative weight that respondents give to an attribute when they make 
choices.  
We then assumed preference follows a discrete distribution, with each cluster q, q 
= 1,…,Q, having a class-specific preference βq that varies between clusters (McFadden, 
1986). The probability of a sequence of choices from individual n is then: 




å .    [5] 
where πq|n is the probability of individual n belonging to class q that is estimated 
simultaneously with the choice model based on the choice patterns (Hole, 2008).  
In order to adjust for potential heterogeneity in variances, we allowed respondents 
in the same preference group to have different scale parameters (Flynn et al, 2010; 
 66 
Magidson and Vermunt, 2007; Campbell et al, 2011). The probability of person n in class 
q choosing medicine i over j in choice task t can be expressed as:  
Pn it b
q, xt( ) = p s|n
1











å    [6] 
where πs|n is the probability of individual n belonging to scale class s, s = 1,…,S, and λs, 
ls Î 0,1( ), is the scale parameter for scale class s that is inversely correlated with the 
variance of choices. The higher the scale gets, the smaller the variance is and the higher 
the certainty level is. To achieve identification, λ1 (i.e., the parameter for scale class 1) is 
normalized to 1.  
We estimated SLCL with two to six preference classes and one to three scale 
classes. Given that Akaike Information Criterion (AIC) may overestimate the number of 
classes (Celeux and Soromenho 1996) and that Bayesian Information Criterion (BIC) has 
been shown to have better performance (Nylund et al, 2007), minimized BIC was used to 
identify the appropriate number of classes. Preference heterogeneity for each attribute 
between classes was tested using Wald test. RAI was calculated and compared across 
classes.  
Finally, we allowed within-class heterogeneity in LCL model by adding random 
effects. We assumed that preference weights for all attribute levels were normally 
distributed with different variances within each class. The preference weights for 
individual n in class q are then:  
bn
q = b q +s qun
q    [7] 
where σq is a vector of standard deviations of preference weights for all attribute levels in 
class q, and un
q  is multivariate normally distributed. The model reduces to LCL when σ = 
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0 for all q, and is the traditional MXL when Q = 1. We estimated RELCL with two to six 
classes, and selected the best-fitted model based on BIC. RAI was calculated and 
compared across classes.  
We compared MXL, LCL, SLCL, and RELCL based on BIC, prediction error, 
and class assignment. To examine the individual characteristics that are associated with 
class membership, demographics, socioeconomic, and health status variables were 
incorporated in the best-fitted model by specifying the class membership probability, πq|n, 
via a multinomial link function with these characteristics. Backward selection was used 
to determine which variables to include in the final model.  
Analysis was conducted in Latent Gold Choice 5.1, which combines Expectation-
Maximization and Newton-Raphson algorithms to estimate maximum likelihood 
solutions of finite mixture models. Because the estimation may sometimes reach local 
maxima that are not representative (Lanza and Rhoades 2011; Nylund et al. 2007), each 
model was replicated 10 times with random starting seeds to look for global maxima. 
Because the probability of choosing a medicine depends only on the differences in levels 
of medicine attributes between two medicines, the first level of each attribute is usually 
normalized to zero. In this study, we used effect-coding to achieve identification. 
Sampling weights were taken into account when calculating standard errors, the latent 
class distribution, and covariate effects.  
3.3 Results 
552 respondents with type 2 diabetes filled out the survey. 543 completed all 
choice tasks and were included in the analysis. The mean age was 61 years. 49% were 
female. The sample has higher percentage of African Americans (23%) and Hispanics 
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(22%) than the general population due to oversampling. Respondents in the sample were 
also more educated and had higher income than the general population. The average type 
2 diabetes history was 11 years. 90% of respondents measured hemoglobin A1c at least 
once in the past six months. 41% had A1c below 7 percent as recommended by clinical 
guideline. Only 7% were not taking any diabetes treatments. 59% of the sample had no 
complications. Majority (77%) reported good, very good, or excellent overall health. 
Most respondents were optimistic about the future (68%) and had been actively 
improving health (69%). (Table 3-2) 
[TABLE 3-2 INSERT HERE] 
All attributes had significant impacts on choices in MXL model (p<0.001) (Table 
3-3). Most effects were in the expected direction. Larger reduction in hemoglobin A1c, 
longer duration of stable blood glucose level, fewer hypoglycemia events, less nausea, 
and lower cost were associated with higher preference weights. In terms of treatment 
burden, respondents were indifferent between having one pill a day (0.334) and having 
two pills a day (0.374) (p>0.05), but had a significantly lower preference weight for 
having injection (-0.708). The standard deviations for all attributes but frequency of 
hypoglycemia (p=0.089) were statistically significant (p<0.05), indicating significant 
preference heterogeneity for the five attributes among respondents. Duration of nausea 
was considered the most important attribute (RAI=0.272), while frequency of 
hypoglycemia was the least important overall for choices (RAI=0.086).  
[TABLE 3-3 INSERT HERE] 
The best-fitted SLCL model contained five preference classes and two scale 
classes. Allowing two scale classes improved BIC from 8440.30 to 8403.18, indicating 
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heterogeneity in scale among respondents. There were significant preference 
heterogeneity for reduction in hemoglobin A1c (p<0.001), duration of stable blood 
glucose level (p=0.001), and treatment burden (p=0.011) across classes (Table 3-4).  
[TABLE 3-4 INSERT HERE] 
Each class in the 5-class SLCL model focuses predominantly on one attribute 
while making choices (Figure 3-2). Class 1 (cost dominant class, 24.0% of sample) 
considered cost the most important attribute (RAI=0.47); class 2 (treatment burden 
dominant class, 23.7%) focused on treatment burden (RAI=0.42) while gave little 
consideration to effectiveness (RAI=0.04); class 3 (nausea dominant class, 22.5%) 
concerned mainly about duration of nausea (RAI=0.56); class 4 (effectiveness dominant 
class, 18.4%) cared most about the amount of reduction in hemoglobin A1c (RAI=0.48); 
and class 5 (effect stability dominant class, 11.4%) made choices largely based on 
duration of stable blood glucose level (RAI=0.43). Overall, 42% of respondents were in 
scale class 2 and were less consistent with their choices (λ=0.339).  
[FIGURE 3-2 INSERT HERE] 
Two classes were identified when random effects were allowed in LCL. 
Preferences for medicine effectiveness (p=0.002), duration of nausea (p<0.001), and 
treatment burden (p<0.001) were significantly different between the classes (Table 3-5). 
Significant within-class preference heterogeneity was found for all attributes in both 
classes (p<0.05), except the preference for frequency of hypoglycemia in class 2 
(p>0.05).  
[TABLE 3-5 INSERT HERE] 
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Figure 3-3 shows that class 1 (cost-effectiveness class, 55.9% of sample) in the 
RELCL model considered cost (RAI=0.26) and the amount of reduction in hemoglobin 
A1c (RAI=0.25) the most important attributes when choosing diabetes medicines, and 
treatment burden the least important attribute (RAI=0.08). Class 2 (side-effect focused 
class, 44.1%) mainly focused on the duration of nausea (RAI=0.37) and treatment burden 
(RAI=0.28) when making choices and valued the effectiveness of medicine less than 
class 1.  
[FIGURE 3-3 INSERT HERE] 
Given that MXL has higher BIC (8587.38) than LCL (8438.82), SLCL (8403.18), 
and RELCL (8350.64), there is likely to be clusters of preferences in the data (Table 3-6). 
Comparing among the discrete models, allowing random effect in LCL dramatically 
reduces the number of classes and increases degree of freedom, despite the additional 
preference variance estimates in each class. In terms of model performance, allowing 
within-class heterogeneity reduces BIC and prediction error (from 15.76% in LCL and 
15.69% in SLCL to 11.61% in RELCL), indicating improved model fit.  
[TABLE 3-6 INSERT HERE] 
Including relevant individual characteristics in the class membership probability 
function in the 2-class RELCL model further reduces BIC (8319.85) and model predictor 
error (11.37%) and improves model fit. Comparing the segmentation results from this 
model to those from SLCL, RELCL combines the cost dominant class (i.e., class 1), 
effectiveness dominant class (i.e., class 4) and most of effect stability dominant class 
(i.e., class 5) in SLCL into one class (i.e., cost-effectiveness class), and the treatment 
burden dominant class (i.e., class 2) and nausea dominant class (i.e., class 3) in SLCL 
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into another class (i.e., side effect focused class) due to proximity of preferences between 
classes (Table 3-7).  
[TABLE 3-7 INSERT HERE] 
Respondents’ age, income level, self-reported health status, current diabetes 
treatment, and perspective about the future were correlated with class membership in the 
2-class RELCL model. A 10-year increase in age was associated with a 0.25 reduction in 
the odds of being in class 1 (p<0.001). Individuals with under $25,000 annual income had 
0.42 higher odds of being in class 1 than the general average (p=0.004). Individuals who 
reported excellent health status had 0.78 higher odds of being in class 1 than general 
average (p=0.005). Currently using insulin injections or insulin injections plus oral 
medicines for diabetes treatment was associated with a 0.74 (p=0.004) and 0.63 
(p<0.001) increase, respectively, in the odds of being in class 1, while having no current 
diabetes treatments was associated with a 1.39 increase in the odds of being in class 2 
(p<0.001). Respondents who reported being optimal about future had 0.27 higher odds to 
be in class 1 (p=0.022). (Table 3-5) 
3.4 Discussion 
This study demonstrates the application of RELCL in modeling unobserved 
preference heterogeneity in the context of health. By comparing various model 
specifications, we tested the assumptions on the underlying distribution of preferences. In 
our DCE data, we first rejected the hypothesis that preference is normally distributed 
across the respondents and found distinct preference types. By allowing random effect, 
we then found two main preference classes with some degree of preference variation 
within each class that is better modeled by a normal distribution than additional classes.  
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Given that type 2 diabetes is a prevalent chronic condition that occurs in a wide 
range of population, patient preference is diverse and difficult to be categorized into 
distinct groups. With more flexible model specification, RELCL better captures this 
complex preference pattern than LCL, where within-class homogeneous preference is 
assumed, leading to improved model fit and prediction accuracy. When the patient group 
is less diverse as in rare diseases or patient preference is less heterogeneous as in acute 
and severe conditions, random effect may not be necessary and LCL may be more 
appropriate to describe the preference patterns. That being said, RELCL can still serve as 
a tool to test the underlying preference distribution in preference studies in health to 
ensure unbiased estimates to support regulatory decision-making.  
RELCL can reduce over-fitting of data. When there is significant within-class 
heterogeneity or overlap between classes, LCL may generate more classes than desired to 
fit the data. Despite better fit, the result is difficult to use by decision-makers. This study 
shows that RELCL combines overlapped preference types and describes some of the 
preference variations using deviation from the mean on a continuous distribution instead 
of additional class. RELCL therefore generates more parsimonious segments than LCL. 
Given that regulatory and clinical decision-makers often prefer parsimonious results due 
to limited financial resources and capacity to accommodate many preference types, 
RELCL can be used to produce more practical results for policy and clinical decision-
making.  
This study found significant preference heterogeneity among patients with type 2 
diabetes. Patients with younger age, lower income, excellent overall health status, 
optimistic view about future or currently using injection to treat diabetes focused on cost 
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and effectiveness when choosing medicine. Patients who were older, have higher income, 
worst overall health status, or not taking any diabetes treatment were more likely to make 
medicine choices based on side effects and treatment burden. These results are consistent 
with some studies in the current literature. For example, Casciano et al (2011) also found 
that administration mode (oral versus injection) was the most important factor when 
diabetic patients chose treatments, but those who were already treated with insulin 
considered side effects, maintenance of blood sugar levels, and risk of hypoglycemia to 
be more important than administration mode. Our findings on the correlation between 
age, income, health status, personality and treatment preference, especially after 
controlling for potential confounding individual factors, complement the current literature 
on patient preference heterogeneity over diabetes treatments.  
The results have significant policy and clinical implications. Cost-effective 
medicines should be provided and recommended to the younger, lower income, and 
relatively healthier group and people who are currently taking injections. Additional pills 
or injection can be used to reduce cost and improve effectiveness if necessary. The older, 
wealthier, and sicker patients as well as those who just start treating diabetes should have 
access to medicines with fewer side effects, even for a higher price or less effectiveness. 
FDA could take such preference into consideration during the drug approval process to 
accommodate different patient needs, and clinicians can choose treatment based on the 
preference types. Given that diabetes requires meaningful patient engagement to improve 
outcomes, tailored treatment will improve adherence and health outcome.  
This study has several limitations. First, it is likely to be underpowered to detect 
more classes. Increasing the number of classes in RELCL generated more separated 
 74 
classes (measured by Entropy R2) and reduced the prediction error. However, because the 
increased number of parameters associated with additional classes dramatically reduced 
degree of freedom, BIC decreased. A larger sample size may allow more parameters and 
more classes. Scale was not adjusted in RELCL to reduce the number of parameters, but 
it is partially incorporated in the within-class preference heterogeneity.  
Second, the true preference heterogeneity distribution is unknown in this 
empirical data, and therefore we were unable to assess how well each model reveals the 
true distribution parameters except using BIC. Future study should use simulation to 
theoretically test the performance of RELCL against LCL and explore under what 
circumstances (e.g. the level of overlap between classes) RELCL performs better than 
LCL. Finally, the sample in this study had higher income and more education than the 
general diabetes patient population. Although sampling weights were used to adjust 
standard errors and latent class distribution, the lower socioeconomic group could have 
different preference over medicine that was underrepresented in the sample. Extra caution 
should be used to generalize the results to the entire diabetes population.  
Despite limitations, this study demonstrated significant preference heterogeneity 
among patients with type 2 diabetes and linked the preference types to some individual 
characteristics. The results can be used to inform patient-centered drug development as 
well as personalized clinical care to improve patient satisfaction and treatment adherence. 
This study also tested several model specifications and demonstrated the approaches to 
studying unobserved preference heterogeneity. It can serve as guidance for researchers 
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Figure 3-1 Sample choice task in the discrete choice experiment survey 
Consider the following two diabetes medicines. Which medicine would you prefer? 
Select one choice – either Medicine A or Medicine B at the bottom of the list.  
Attributes Medicine A Medicine B 
A1c levels go down by 1% 0.5% 
Stable blood glucose 2 days per week 4 days per week 
Low blood glucose During the day None 
Nausea None 30 minutes per day 
Additional medicine 2 pills per day 1 pill per day 
Additional out-of-pocket costs $50 per month $30 per month 
Which medication would you 
choose? (pick one) 
I would choose 
Medicine A 
☐ 



















Stable A1c Hypoglycemia Nausea Treatment
Burden
Cost
Class 1 Class 2 Class 3 Class 4 Class 5
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Table 3-1 Attributes and levels included in the discrete choice experiment survey 
Attribute Levels 
Reduction in hemoglobin A1c level   1% 
 0.5% 
 0% 
Duration of blood glucose level remaining stable   6 days per week 
 4 days per week 
 2 days per week 
Frequency of hypoglycemia  None 
 During the day only 
 During the day and/or at night 
Duration of nausea  None 
 30 minutes per day 
 90 minutes per day 
Treatment burden in addition to current medicine  1 pill per day 
 2 pills per day 
 1 pill and 1 injection per day 
Out-of-pocket cost  $10 per month 
 $30 per month 




Table 3-2 Respondent characteristics 
 N Percent 
Demographic Characteristics 
Age (mean) 552 61.30 
Gender   
Male  279 0.51 
Female 273 0.49 
Race   
White 289 0.52 
Black 126 0.23 
Hispanic 119 0.22 
Other  18 0.03 
Education   
Less than high school 43 0.08 
High school 188 0.34 
Some college 156 0.28 
Bachelor’s degree or higher 165 0.30 
Income   
< 25,000 132 .24 
25,000 – 50,000 148 .27 
50,000 – 74,999 111 .20 
≥ 75,000 161 .29 
Health-related Characteristics 
Years of diagnosis (mean) 545 11.24 
Self-Reported Health   
Excellent 33 .06 
Very good 158 .29 
Good 232 .42 
Fair 106 .19 
Poor 23 .04 
No. A1c measured in last 6 months   
None 41 .07 
1 time 239 .43 
> 2 times 261 .47 
Don’t know 10 .02 
Most recent A1c level   
≥ 7.0% 233 .43 
< 7.0% 228 .41 
Don’t know 89 .16 
Type of diabetes medicine used   
No prescription medicine 37 .07 
Only pills 345 .63 
Only injections/shots 42 .08 
Pills and injections/shots 127 .23 
No complications 326 .59 
No other chronic conditions 92 .17 
Personality Characteristics   
Agree or strongly agree with the following statement 
I’m always optimistic about my future 372 .68 
I have a lot of self-control 316 .57 
I’m actively working to improve my health 375 .69 
I consider myself a risk-taker 98 .18 
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Table 3-3 Estimates from the mixed logit model 
Attributes Coefficient (SE) p-valuea Std. Dev. (SE) p-valuea RAIb 
A1c reduction 
  
   
1%  0.364*** (.056) <.001 0.488*** (.078) <.001 .162 
0.50%  0.218*** (.049) 
 
0.103**  (.040)   
0% -0.581*** (.057) 
 
0.591*** (.083)   
Stable glucose 
  
   
6 days/week  0.283*** (.044) <.001 0.176**  (.055) .003 .107 
4 days/week  0.060     (.047) 
 
0.078*   (.039)   
2 days/week -0.343*** (.042) 
 
0.098    (.057)   
Hypoglycemia 
  
   
None  0.193*** (.038) <.001 0.099*   (.046) .089 .086 
Day  0.115*    (.046) 
 
0.021    (.040)   
Day & night -0.308*** (.038) 
 
0.078    (.049)   
Nausea 
  
   
None  0.704*** (.063) <.001 0.787*** (.067) <.001 .272 
30 min/day  0.180*** (.038) 
 
0.090*   (.044)   
90 min/day -0.885*** (.064) 
 
0.877*** (.069)   
Treatment burden 
 
   
1 pill  0.334*** (.049) <.001 0.375*** (.056) <.001 .185 
2 pills  0.374*** (.055) 
 
0.256*** (.057)   
1 pill & 1 injection -0.708*** (.059) 
 
0.631*** (.092)   
Cost 
  
   
$10/month  0.526*** (.084) <.001 0.839*** (.093) <.001 .189 
$30/month  0.054     (.097) 
 
0.093     (.100)   
$50/month -0.580*** (.089) 
 
0.746*** (.074)   
a. P-values were from the Wald-test.   b. RAI: relative attribute importance.  




Table 3-4 Estimates from the 5-class 2-scale-class latent class logit model 
Attributes Coefficient (SE) Wald(=)a 
Class 1 Class 2 Class 3 Class 4 Class 5 p-value 
A1c reduction       
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Class Share  0.240  0.237  0.225  0.184  0.114  
a. Wald test for equal impact of each attribute across classes.  
*p<0.05 **p<0.01 ***p<0.001 
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Table 3-5 Estimates from the random effect latent class logit model with individual 
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Age  -0.029*** 
(.007) 
0.972***  0.029*** 
(.007) 
1.029*** <.001 
Income       







0.941  0.061 
(.132) 
1.063   
$50,000-74,999 -0.307* 
(.132) 
0.736*  0.307* 
(.132) 
1.359*   




0.985   
Health status       





Very good -0.225 
(.146) 
0.799  0.225 
(.146) 
1.252   
Good -0.058 
(.120) 
0.944  0.058 
(.120) 
1.059   




0.894   
Poor -0.407 
(.229) 
0.666  0.407 
(.229) 
1.502   
Current treatment        
No treatment -0.869*** 
(.267) 
0.419***  0.869*** 
(.267) 
2.385*** <.001 
Only pills -0.175 
(.135) 
0.839  0.175 
(.135) 
1.191   




0.574**   




0.613**   
Optimistic about future      
Disagree -0.024 
(.166) 





0.808  0.213 
(.122) 
1.237   




0.789*   
Class Share  0.559   0.441    
a. Wald tests for equal preference estimates and equal variances across classes.  
b. The coefficients are log odds ratios with effect coding.  
*p<0.05 **p<0.01 ***p<0.001 
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Table 3-6 Model statistics of mixed logit, 6-class latent class logit, 5-class 2-scale-
class latent class logit, and 2-class random effect latent class logit a 
 LL BIC Npar df Entropy R2 Pred. Err. 
MXL -4218.12 8587.38 24 519 1 0.130 
6-class LCL -3976.97 8438.82 77 466 0.832 0.158 
5-class 2-sclass SLCL -3993.79 8403.18 66 477 0.773 0.157 
2-class RELCL -4021.04 8350.64 49 494 0.681 0.116 
a. None of the models include individual characteristics.  
MXL: mixed logit; LCL: latent class logit; SLCL: scale-adjusted latent class logit; 
RELCL: random effect latent class logit; LL: log-likelihood; BIC: Bayesian Information 




Table 3-7 Cross-tab between class membership in the 5-class scale-adjusted latent 
class logit model and class membership in the 2-class random effect latent class 
model a 
  RELCL  














































 Total 296 245 541 
a. Random effect latent class model includes individual characteristics.  







Chapter 4 Using Latent Class Analysis To Analyze Preference 
Heterogeneity In Best-Worst Scaling Data: A Comparison of 
Latent Class Logit And Standard Latent Class Models 
 




Latent class logit (LCL) models have been commonly used to analyze preference 
heterogeneity in stated-preference studies. With an increasing use of best-worst scaling 
(BWS) to assess priorities in healthcare in the past few years, researchers started to apply 
LCL in BWS data. However, information criteria often fail to identify the best-fitted 
model when LCL is used to segment discrete choice data from BWS. This paper proposes 
alternative models for this emerging preference elicitation technique, specifically, 
applying the standard LC model on the best or worst choices or best-worst scores.  
We test the model using data from a national survey among patients with type 2 
diabetes on barriers and facilitators for diabetes self-management. The survey contains a 
BWS (case 1) experiment with 11 choice tasks generated from a balanced-incomplete-
block design. The standard LC model with best and worst choices both identifies five 
classes based on minimized BIC. The LC model with best-worst scores includes four 
classes, but the segments are comparable to those from the best/worst choice model. 
Instead of LCL, researchers should consider more flexible model specifications to 






Best-worst scaling (BWS) has been increasingly used to measure priorities in 
health (Cheung et al., 2016). Unlike the traditional ranking and rating methods, BWS 
repeatedly presents subsets of objects to be prioritized and asks respondents to select the 
most and least important object in each set (Muhlbacher et al., 2016). Based on repeated 
comparison and choices, BWS ranks all objects in terms of importance. In healthcare, the 
priorities of patients and other stakeholders measured by BWS have been used to direct 
clinical care and policy (Cheung et al., 2016). For example, knowledge about patients’ 
priorities on clinical outcomes allows clinicians to tailor treatment plan to patients’ goals 
(Lynd et al., 2016).  
Recent movements towards patient-centered drug development from the 
regulatory agency (Califf, 2017) and patient-centered care among healthcare providers 
(Epstein et al., 2011) emphasize the importance of learning heterogeneity in patient 
preferences and priorities. Latent class analysis (LCA) is a common method to study 
unobserved preference heterogeneity. It groups individuals into like-minded clusters 
based on their preference or priority (Cunningham et al., 2008; Hole, 2008). Despite its 
wide application in stated-preference studies, LCA has not been commonly used to 
analyze heterogeneity in priorities, especially those measured by BWS.  
A systematic review we conducted earlier found that only five articles applied 
segmentation methods to study heterogeneity in priority measured by BWS case 1 (object 
case). Four studies used latent class logit (LCL) model (Feudtner et al., 2015; Fraenkel et 
al., 2015; Virudachalam et al., 2016; Yan et al., 2015), and one study used k-mean 
clustering analysis for segmentation (Liang et al., 2016). None of the studies explained 
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model specification or model selection process. Given that the application of LCA in 
BWS data has not been fully examined, this study sought to show the challenges of using 
LCL, the most commonly used segmentation method in stated-preference studies, to 
analyze heterogeneity in BWS data and propose alternative model specifications. We 
hypothesize that more flexible model specification will improve model fit, leading to 
more reliable preference estimates and prediction of choices to support policy and clinical 
decision-making.  
This study uses BWS data from a national survey among patients with type 2 
diabetes on the barriers and facilitators for diabetes self-management. Type 2 diabetes is 
chosen as a case study because it represents a chronic illness that requires meaningful 
patient engagement to improve disease management and outcomes. Learning how the 
barriers and facilitators for diabetes self-management vary among different patients will 
enable clinicians to tailor treatment plan based on patient priority and improve treatment 
adherence as well as outcomes. Given that diabetes affects nearly 30 million individuals 
in the US (CDC, 2014), the result will have significant clinical implications. The 
remainder of this paper is organized as follows. Section 2 describes the BWS survey and 
sample characteristics. Section 3 shows the challenge of using LCL model in BWS data 
and proposes alternative models to analyze heterogeneity in priority. Section 4 presents 
the results and section 5 discusses the methodological and clinical implications.  
4.2 Data 
We collected data on barriers and facilitators for diabetes self-management among 
patients with type 2 diabetes using BWS case 1 (object case). 11 factors were purposely 
selected from literature reviews, focus group interviews, and repeated feedback from 
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local patients to represent both known barriers and facilitators of patients’ diabetes 
management (Table 4-1). A balanced-incomplete block design (BIBD) generated 11 
choice tasks. Each task included a subset of five factors and asked respondents to choose 
the factors with the best impact and worst impact on their own diabetes self-management. 
Each factor appeared five times and was compared to every other factor twice across the 
11 choice tasks.  
[TABLE 4-1 INSERT HERE] 
Figure 4-1 presents one example choice task. Respondents were asked to 
complete all 11 choice tasks that were presented in random order. Detailed explanation of 
the factors was provided to respondents before they answered the choice tasks. The 
survey questions as well as the framing of the information was pretested and piloted 
among local patients to make sure they were understandable. In addition to BWS choice 
tasks, the survey also included questions on the respondents’ diabetes history, current 
disease management, health status, and personalities using Likert scales.  
[FIGURE 4-1 INSERT HERE] 
A national survey was conducted among patients with type 2 diabetes through the 
GfK KnowledgePanel in 2015. It is an online panel that provides sampling coverage of 
97% of the US adult population (Couper, 2000), and has been shown to have over 4,000 
potential patients with type 2 diabetes, with a high proportion of complex patients 
(Safford et al, 2007). 554 respondents filled out the survey. 536 who completed all choice 
tasks and did not select the same object as both best and worst in any of the choice tasks 
are included in the analysis.  
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The mean age was 61.6 years. 46.8% of the respondents were female. African 
Americans and Hispanics were oversampled (22.6% and 21.6%, respectively) due to 
higher prevalence of diabetes (CDC, 2014) and lower adherence rates to treatments 
(Egede et al, 2011). Over 90% of the sample had at least high school degree, and almost 
half had above $50,000 annual income. The average length of diabetes diagnosis was 11 
years. About 90% of sample measured hemoglobin A1c at least once in the past six 
months. 39.9% had A1c below 7 percent, and 58.8% had no complications. Only 8.2% of 
the sample was not taking any diabetes treatments. Majority (73.9%) reported good, very 
good, or excellent overall health. Half of the respondents reported having self-control and 
only 16.6% reported to be risk-taker. (Table 4-2) GfK calculated sample weights to 
rebalance the sample to national norms for the assessment of aggregate results.  
[TABLE 4-2 INSERT HERE] 
4.3 Model specifications 
4.3.1 Latent class logit model 
We first estimated a latent class variant of the sequential best-worst model 
(Marley and Louviere, 2005) to analyze heterogeneity in priority given its common 
application in discrete choice data as well as in the few BWS studies in health. The model 
assumes that individuals choose the best and worst options in a choice task in two 
independent steps. They first choose the best object with the highest utility and then the 
worst object with the lowest utility among the remaining options. The utility an 
individual n derives from factor i in choice task t is:  
Unit = bnixnit +enit      [1] 
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where xnit is usually the characteristics for object i, but in the case of BWS (object case), 
it is an object specific dummy variable for factor i, and βni then measures the utility 
individual n assigns to object i. εnit is a random disturbance term that represents the 
random fluctuations when the decision maker makes choices (McFadden, 1974). When ε 
is assumed to follow an independent type I extreme value distribution, the probability of 
individual n choosing object i as the best in choice task t becomes:  












   [2] 
given that xs are object specific dummies. To achieve identification, one utility parameter 
needs to be normalized to zero. This study uses effect coding and therefore βi measures 
the relative utility for object i compared to the mean utility across all objects. The 
probability of individual n choosing object i as best and k as worst in choice task t is:  











    [3] 
assuming the probability of an object being chosen as worst depends on the magnitude of 
the negative relative utilities of all objects in the remaining choice set. That is, the object 
with the largest negative relative utility (i.e. the smallest positive relative utility) will 
have the highest probability to be chosen as worst.  
LCL model assumes the individual utility parameters to be random draws on a 
discrete distribution with distinct groups (McFadden, 1986). With different class-specific 
parameters and class membership probability, LCL captures the inter-personal preference 
heterogeneity as well as the intra-personal correlation in responses to different choice 
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tasks. Suppose there are Q distinct groups, the likelihood of a sequence of choices from 
individual n is:  







å     [4] 
where y is a vector of best and worst choices from the 11 choice tasks, yt is the best and 
worst choices from choice task t, πq|n is the probability of person n belonging to class q, 
and βq is a vector of class-specific utility parameters for the factors in class q. We 
estimated the LCL model with one to ten classes with effects coding. Bayesian 
Information Criterion (BIC) was used to identify the appropriate number of classes, given 
that it has been shown to have better performance than other criteria (Nylund et al, 2007). 
Each model was replicated 10 times with random starting seeds to look for global 
maxima. 
Figure 4-2 shows the BICs from the LCL models. As the number of classes 
increases from one to ten, BIC continues decreasing, indicating model over-fit. For a 
sensitivity check, we 1) allowed different scale for the worst choices in LCL, 2) allowed 
two scale classes to account for different consistency of choices among different 
respondents, and 3) estimated the best only and worst only models to avoid the 
dependency between best and worst choices. However, none of the adjustments led to a 
best-fitted model with fewer than ten classes. Instead of assuming sequential best-worst, 
we also considered alternative choice behavior assumption. The maximum difference 
logit (max-diff) model assumes that individuals consider all possible pairs within a choice 
set and choose the pair with maximum difference in utility (Marley and Louviere, 2005; 
Marley et al., 2008). However, estimates from the max-diff model were almost identical 
to those from LCL, which is consistent with findings from previous studies (Flynn et al., 
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2008). Alternative model specifications are needed to analyze heterogeneity in BWS 
data, and we propose two models in this study.  
[FIGURE 4-2 INSERT HERE] 
4.3.2 Standard latent class model on best and worst choices 
We first apply a standard LC model on the 11 choice tasks as 11 categorical 
outcome indicators. We start with assuming choices across the tasks are independent 
given the class-specific preferences. However, the best and worst choices within a choice 
task are dependent. Allowing dependency between best and worst across 11 tasks will 
dramatically complicate the model and reduce degree of freedom. Given that we have 
relatively limited sample size for 11 outcome indicators, the best and worst choices are 
analyzed separately. We assume the worst choice is selected out of all five options in a 
choice task, instead of five options less the best as suggested in the sequential best-worst 
model, to ensure same choice set across respondents. Given that there could be a mixture 
of choice behaviors among respondents (i.e. best-worst, worst-best, or simultaneous 
choices) that is unknown, this assumption is a valid compromise. Each indicator then has 
five possible outcomes. Using the notation above, the probability of individual n 
choosing object i as best (or worst) in choice task t can be written as: 
 






    [5] 
where βnit is individual n’s utility (or disutility) for object i in choice task t. When there 
are Q distinct classes, the utility for object i in choice task t of respondents in class q is 
specified as bnit = bit +bit
q . The likelihood of a sequence of choices from individual n is 
the same as equation [4].  
 98 
Compared to LCL, the standard LC model allows the utility parameter (β) for 
each object to vary across different choice tasks. Restricted by a cross-task constant 
utility constraint, the utility parameter in LCL measures the average utility for an object 
across all choice tasks. With 11 choice tasks and potential intra-personal inconsistency in 
choices compared to preferences, there can be a wide variety of choice sequences, 
leading to hundreds of utility values for each object across respondents. Segmentation on 
11 indicators with hundreds of potential outcomes can lead to many classes. The standard 
LC model relaxes such constraint. Because there are only five possible outcomes in each 
choice task, the utility parameters take on a much smaller set of values. We hypothesize 
that despite a larger number of parameters, the standard LCL model leads to more 
parsimonious segmentation results.  
We estimate the standard LC model on best and worst choices separately with one 
to ten classes and use BIC to choose the most appropriate number of classes. Each model 
is replicated 10 times with random starting seeds to look for global maxima. As the 
choice tasks repeatedly present subsets of objects, it is likely that choices from some 
tasks are correlated. Based on the output from the independent model, we relax the local 
independency assumption by allowing association between indicators with large bivariate 
residuals. Suppose choice task t1 is correlated with choice task t2. The two dependent 
variables then serve as a joint dependent indicator. The likelihood of a sequence of 
choices becomes: 
Ln y( ) = pq nPnt1t2 t1 = i, t2 = j b





å   [6] 
where the linear term in the logit model for Pnt1t2 t1 = i, t2 = j b
q( )  is  
 99 
bnijt1t2 = bit1 +bit1
q +bit2 +bit2
q +bijt1t2 .  
We then compare the estimates from models with and without local independence 
assumption.  
Using the estimates from the best-fitted model, we calculate the average 
conditional probability for each object across the five choice tasks in which it appears. 
Because of the balanced design in the survey, the average conditional probabilities are 
comparable across objects and therefore are used to generate a full ranking of the 11 
objects for each class. We then perform a multinomial logistic regression to examine the 
individual characteristics that are associated with class membership. Sampling weights 
are taken into account when calculating standard errors, the latent class distribution, and 
covariate effects.  
4.3.3 Standard latent class model on best-worst scores 
One weakness of the standard LC model above is that the segmentation is based 
on only best or worst choices. In order to cluster respondents based on both choices 
without considering specific choice behavior, we apply a standard LC model on best-
worst (BW) scores. BW score of each object is calculated for each respondent by 
subtracting the number of times an object is selected as worst from the number of times 
the object is selected as best. Given that each object appears five times in the 11 choice 
tasks, BW score ranges from -5 (i.e., an object is selected as worst every time it appears) 
to 5 (i.e., an object is selected as best every time it appears). A standard LC model is 
applied to the 11 BW scores as 11 outcome indicators. Again, we first assume local 
independence between the BW scores for different objects. To reduce the dimension of 
LC model and avoid over-fitting, BW scores are grouped into five categories, i.e., -5 to -
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4, -3 to -1, 0, 1 to 3, and 4 to 5. The probability of an object i getting a BW score that is 










    [7] 
where bmi  is the mean log odds ratio for object i to have a BW score in category m, and 
bmi
q  is the difference in mean log odds ratio for object i to have a BW score in category m 
between all respondents and those in class q. Because the 5-category BW score is an 
ordinal indicator, we restrict that bmi
q = bi
q × zmi, where zmi  is the score assigned to 
category m of BW score for object i, which yields an ordinal logit model. The likelihood 
of a sequence of BW scores from individual n is: 







å     [8] 
where y is a vector of BW scores for the 11 objects. Intuitively, LC is performed on 11 
ordered logit regressions of BW scores. We estimate the model with one to ten classes 
and use BIC to choose the appropriate model. Based on the bivariate residuals between 
indicators in the model output, we relax the local independence assumption by allowing 
correlation between indicators, and then compare the estimates to those from the 
restricted model. Multinomial logit regression is used to explore the correlation between 
individual characteristics and class membership in the best-fitted model. Standard errors, 
latent class distribution, and covariate effects are adjusted using sampling weights.  
4.4 Results 
All factors were selected at least 10 times as best and at least 22 times as worst in 
each choice task across all respondents, indicating large variation in choices between 
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respondents. By allowing task-specific parameters, the standard LC model on both 
best/worst choices and BW scores dramatically reduced the number of classes and 
identified four to five classes based on minimized BIC. Large bivariate residuals exist 
between outcome indicators in both best/worst choice model and BW score model, 
suggesting correlation between choice tasks and between BW scores of different factors. 
However, relaxing local independence assumption did not significantly change the 
segmentation results.  
4.4.1 Standard latent class model on best and worst choices 
The optimal LC model on best choices identified five facilitator classes. 
Healthcare providers, support from family and friends, access to healthy food, staying 
motivated, and the ability to pay were the greatest facilitator for diabetes self-
management among respondents in class 1 (provider-driven class, 26.2% of the sample), 
class 2 (support-driven class, 21.9%), class 3 (healthy food-driven class, 21.0%), class 4 
(motivation-driven class, 18.1%), and class 5 (affordability-driven class, 12.8%) 
respectively (Figure 4-3). Respondents’ knowledge about diabetes was the second most 
influential facilitator in all classes except class 2 where family commitment was also 
important.  
[FIGURE 4-3 INSERT HERE] 
In terms of class characteristics, a 10-year increase in age was associated with a 
5% increase (p=0.003) in the probability of being in the provider-driven class (Table 4-
3). African Americans were 12.7% (p=0.024) more likely to be in the affordability-driven 
class and 9.1% (p=0.049) less likely to be in the health food-driven class compared to the 
white counterparts. Hispanics were 17.0% (p=0.002) less likely to be in the provider-
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driven class than whites. Patients with high school and bachelor degrees were 13.0% 
(p=0.024) and 15.1% (p=0.037), respectively, more likely to be in the support-driven 
class than those without high school degree. Poorer overall self-reported health status was 
correlated with higher probability of being in the support-driven class (p<0.05), while 
patients who reported poor health were 24.0% (p=0.050) less likely to be in the provider-
driven class. In terms of personalities, individuals who reported having self-control were 
11.8% more likely to be in the motivation-driven class than the rest (p=0.024). Patients 
who reported to be risk-takers were 15.5% (p=0.031) more likely to be in the support-
driven class and 17.4% (p=0.001) less likely to be in the provider-driven class.  
[TABLE 4-3 INSERT HERE] 
The standard LC model with the worst choices identified five barrier classes. 
Work commitments and local events were the greatest barriers for diabetes self-
management for respondents in class 1 (work-committed class, 38.4% of the sample). 
Ability to pay was the single leading barrier for class 2 (affordability-lacking class, 
22.2%). Staying motivated was the primary barrier for class 3 (motivation-lacking class, 
19.2%), followed by other health conditions. Support from family and friends and staying 
motivated were the most important barriers for class 4 (support-lacking class, 10.6%). 
Access to healthy food was the most influential barriers for class 5 (healthy food-lacking 
class, 9.7%), while lack of motivation, ability to pay, and other health conditions were 
also important (Figure 4-4).  
[FIGURE 4-4 INSERT HERE] 
Hispanics were 6.6% (p=0.004) less likely to be in the healthy food-lacking class, 
while Asians were 19.3% (p<0.001) less likely to be in the affordability-lacking class 
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than the white counterparts (Table 4-4). Patients with high school and bachelor degrees 
were 13.3% (p=0.041) and 16.9% (p=0.025), respectively, more likely to be in the 
motivation-lacking class than those without high school degrees. Income was positively 
correlated with the probability of being in the motivation-lacking class (p<0.05). Poorer 
health status was associated with lower probability of being in the healthy-food-lacking 
class and higher probability of being in the motivation-lacking class (p<0.05). Patients 
with hemoglobin A1c below 7% were 5.6% (p=0.022) less likely to be in the healthy 
food-lacking class. Patients who didn’t know their A1c level were 12.4% (p=0.034) more 
likely to be in the health food-lacking class. Individuals who had self-control were 16.0% 
more likely to be in the work-committed class (p=0.017). Risk-takers were 14.1% less 
likely to be in the motivation-lacking class (p=0.006).  
[TABLE 4-4 INSERT HERE] 
4.4.2 Standard latent class model on best-worst scores 
The 5-class LC model with BW scores has the lowest BIC (15751.99), but 
because one class in the model only has 3% of the respondents, we selected a more 
parsimonious 4-class model (BIC=15754.21), which also has the lowest consistent AIC 
among all. Figure 4-5 shows the conditional probability of each object getting a BW 
score in each category by class. In class 1 (27.9% of the sample), knowledge and 
motivation were the greatest facilitators for diabetes self-management, while ability to 
pay was the leading barrier. Class 2 (24.5%) identified support from others, healthcare 
providers, and family commitment as the main facilitators and other health condition and 
staying motivated the major barriers. Knowledge, motivation, healthcare providers, and 
access to healthy food were all facilitators for respondents in class 3 (24.0%), while local 
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events and work commitments were the main barriers. Class 4 (23.7%) chose knowledge 
and ability to pay as important facilitators, followed by access to healthy food and 
healthcare providers, and selected support from others, motivation, other health 
conditions, and family commitment as major barriers.  
[FIGURE 4-5 INSERT HERE] 
In terms of class characteristics, individuals who were widowed, divorced or 
separated and those who were never married were 13.8% (p=0.005) and 22.7% 
(p<0.001), respectively, less likely to be in class 2 compared to those who were married. 
Patients with high school and bachelor degrees were 23.4% and 21.9%, respectively, 
more likely to be in class 2 (p<0.001), while 24.1% (p=0.037) and 27.4% (p=0.034), 
respectively, less likely to be in class 1 than those without high school degree. Patients 
with over $75,000 annual income were 16.2% more likely to be in class 4 than those with 
under $25,000 annual income (p=0.040). Poorer overall health status was correlated with 
higher probability of being in class 2 (p<0.05). Patients with hemoglobin A1c below 7% 
were 10.4% less likely to be in class 1 (p=0.032). Individuals who reported having self-
control were 16.7% (p=0.002) more likely to be in class 3 and 13.9% (p=0.036) less 
likely to be in class 4. (Table 4-5) 
[TABLE 4-5 INSERT HERE] 
Table 4-6 describes the cross-tab between the class membership from BW score 
model and the class membership from best/worst choice model. It summarizes how the 
BW score model combines and redistributes the barrier and facilitator classes. Class 1 
mainly took respondents in the affordability-lacking class (71.8%), with half of the 
motivation-driven class who may be the same group of individuals. Class 2 was mainly 
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from the support-driven class, with half of the motivation-lacking class that may be 
related. Majority of class 3 were from the work-committed class. Class 4 combined 
affordability-driven class with motivation-lacking and support-lacking classes. 
Segmentation results from the BW score model were consistent with those from the 
best/worst choice models. Performing LC on BW score just incorporates the facilitator 
and barrier classes generated from the best and worst choices with consideration of the 
correlation between the two parts.  
[TABLE 4-6 INSERT HERE] 
4.5 Discussion 
This paper identified the issue with applying LCL model in BWS object case data 
to analyze heterogeneity, specifically, the challenge of finding the appropriate number of 
classes using information criteria such as BIC. The issue rises when there are many 
choice tasks in a survey and there is large variation in the choice sequence among 
respondents. This is because in these cases the cross-task equal utility constraint in the 
LCL model leads to large variation in the utility parameters across respondents. 
Segmentation on a large set of indicators, each with hundreds of possible outcomes, can 
lead to a large number of classes. The BWS survey in this study had 11 prioritization 
factors and choice tasks as well as large variation in choice sequence among the 
respondents. BIC from the LCL model was therefore unable to reach minimum within ten 
classes.  
LCL model may lead to parsimonious segmentation results only when there are a 
limited number of choice patterns across respondents, meaning that there are only a few 
priority types among respondents and there is little inconsistency between choices and 
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priorities (i.e., disturbance terms in the utility function barely affect choices). Given that 
over half of BWS case 1 studies in health include over 10 prioritization objects (Cheung 
et al., 2016), LCL model is unlikely to lead to practical segmentation results. Increasing 
sample size may also exacerbate the issue due to additional priority types and larger 
inconsistency in choices among additional respondents, especially when we study the 
priority of a diverse population such as the diabetes patients in this paper. The few studies 
in the current literature that used LCL to analyze BWS data selected the number of 
classes based on interpretation of the classes. Model fit, however, should be considered to 
ensure reliable estimates and predictions.  
We proposed two alternative models to analyze heterogeneity in BWS data in this 
paper. We first used a standard LC model to separately analyze best and worst choices, 
allowing utility parameter for each object to vary in different choice tasks. This is 
equivalent to a LC analysis on 11 multinomial logistic regressions with only object 
specific constant as predictor. Because respondents make choices based on a comparison 
of options within a choice task and their relative utility, the task-specific utility 
assumption is consistent with choice behavior. Another assumption in the model is that 
both best and worst choices are selected from all options in a choice set. Given that 
sequential best-worst and max-diff assumptions often lead to similar results (Flynn et al., 
2008), we argue that the assumption on choice behaviors would not affect segmentation 
results. However, future research can test this hypothesis by allowing sequential best-
worst, worst-best, and max-diff and examining the impact of choice behavior assumption 
on segmentation results. Overall, the flexible model specification led to more 
parsimonious segments, despite additional parameters to be estimated.  
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One weakness of the standard LC model with choices as outcome is that it is 
difficult to accommodate both best and worst choices in the model when there are many 
choice tasks (i.e. outcome indicators). This is because the dependence between the best 
and worst choices requires additional correlation parameters that further complicate the 
model structure. To address this issue and incorporate both best and worst choices 
without further reducing degree of freedom, we applied a standard LC model on BW 
scores, a single measure that reflects both choices. The model led to parsimonious 
segments that are comparable to those from the best/worst choice models. Specifically, 
segmentation based on BW scores combines and regroups classes from the individual 
best and worst choice models. However, future research can consider including both best 
and worst choices in the choice model and allowing local dependence between the two 
outcomes when there are fewer prioritization objects and larger sample size. The results 
can be compared to the BW score model.  
We found substantial heterogeneity in both barriers and facilitators for diabetes 
self-management among patients with type 2 diabetes. Older patients were more likely to 
identify healthcare providers as the main facilitator for diabetes self-management, 
probably because of more access to healthcare due to Medicare. African Americans were 
not likely to benefit from access to healthy food, but were likely to report ability to pay as 
a facilitator for their diabetes management. Hispanics did not have an issue with access to 
healthy food, but were unlikely to receive help from healthcare providers. Support from 
family and friends and family commitment facilitated diabetes management among 
individuals who were married. The more educated patients also benefited the most from 
support from others. They did not have an issue with ability to pay, but could have 
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trouble staying motivated. Due to sufficient financial resources, the high-income group 
had good access to healthcare providers and healthy food. They reported their ability to 
pay facilitated their diabetes management, but like the educated group, they could have 
trouble staying motivated. In addition, family commitment and lack of support from 
others could also negatively affect their disease management.  
Patients with poorer overall health were more likely to report other health 
conditions jeopardized their diabetes management. They were likely to lack motivation, 
but benefit most from support from others. Healthcare providers were unlikely to be a 
major facilitator for those with the poorest health, possibly due to limited healthcare 
access. Patients with hemoglobin A1c above 7% were more likely to report ability to pay 
as a barrier and rely on knowledge and motivation to manage diabetes. Work 
commitment was the leading barrier for patients who reported having self-control, while 
motivation was the major facilitator in this group. Individuals who reported to be risk-
takers did not have issue staying motivated. Their disease management was not likely to 
be facilitated by healthcare providers but support from others.  
Majority of the studies in the currently literature focus on examining the impact of 
individual factors, such as economic resources, social networks, and health knowledge, 
on diabetes management, and few studies ask patients to prioritize them. This study fills 
the knowledge gap by ranking the barriers and facilitators from the patients’ perspective 
and, more importantly, segmenting patients based on their priorities to learn the 
heterogeneity among different individuals. Segmentation based on priorities sometimes 
gives contradicting findings from stratification on individual socio demographic 
characteristics. For example, Chelbowy et al. (2013) found gender differences in the 
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barriers and facilitators for diabetes self-management among African American adults, 
which was not observed in our study. This is possibly because other individual 
characteristics (e.g., income, education, personality) were controlled for in the 
multivariate analysis of the correlation between an individual covariate and class 
membership. By controlling for potential confounding, we were able to identify the key 
factors associated with different priority types.  
Our findings are consistent with the current literature on that the variation in 
diabetes self-management as well as the barriers and facilitators reflects individuals’ 
knowledge, option, and personality more than patients’ age, gender, or culture 
(Onwudiwe et al., 2011). We found that access to healthcare, social support and 
motivation were the three main themes affecting diabetes self-management. According to 
our findings, expanding healthcare coverage for the uninsured or under-insured, 
motivating those who are educated, high-income or sick, reducing work pressure for the 
motivators, and enhancing social support for the high-incomes would be the most effect 
way to improve diabetes management and health outcome in these groups. Clinicians can 
consider such diversity and tailor their treatment and disease management plans based on 
individual needs.  
There are a few limitations in this study. First, the sample size is relatively small 
given the number of objects examined in the study. As a result, we were not able to allow 
correlation between all pairs of choice tasks with large bivariate residuals. However, the 
local dependence constraint was relaxed for the strongest correlated tasks and it did not 
significantly change the segmentation results. Future research with larger sample size can 
allow more correlated pairs or even incorporate both best and worst choices in the model. 
 110 
Moreover, we conducted a post-estimation analysis to examine class characteristics to 
reduce the complexity of the model. With larger sample size, future research can consider 
including individual characteristics in the multinomial logit function for class 
membership to improve segmentation.  
Second, patient insurance information is missing in the data. As we included most 
socio demographic characteristics, health and disease-related variables, and personalities 
traits, we were unable to control for health insurance status. Given some findings such as 
the insignificant correlation between income and the probability of patients reporting 
ability to pay as a main barrier, we hypothesize that health insurance status plays an 
important role in diabetes self-management. If so, the results are confounded. In addition, 
the limited employment information (i.e., employed, unemployed, retired) did not allow 
us to identify the specific group who reported work commitment as the leading barrier. It 
may be valuable to further examine these two factors in future research.  
Third, respondents in the sample have higher income and education level than the 
general population, even among the minorities. This could be the reason why we found 
that African Americans were more likely to report ability to pay as a facilitator for 
diabetes self-management. Although we used sample weights to adjust standard errors, 
latent class distribution, and covariate effects and controlled for socioeconomic status 
such as income and education, the priorities from the low-income, low-education 
minority groups could still be underrepresented in the sample. Therefore, researchers 
should use caution to generalize the results.  
Finally, we were not able to validate the individual priority as well as the priority 
types revealed in our analysis with those obtained from other sources. We compared the 
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priority segments across different model specifications and tested the convergent validity. 
However, it is unclear if the BWS survey revealed the true priorities among respondents. 
Future research can use other prioritization methods, such as ranking, in addition to BWS 
to study priority to allow validation across methods.  
Despite the limitations, this paper identifies the issue of applying LCL model to 
analyze BWS data and proposes alternative model specifications that are more suitable 
for the BWS data structure. Depending on the study objective, researchers can apply the 
standard LC model on either best/worst choices to separately examine barriers and 
facilitators or BW score to capture both answers. In either model, researchers should 
consider flexible model specification to allow conditional probability for each object to 
vary in different choice scenarios. Improved model fit would lead to reliable estimates 
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Figure 4-1 Sample choice task in the best-worst scaling survey 
Consider the following things that can have a positive or negative impact on your own 
diabetes self-management. Which of the following things is the best and which is the 
worst in terms of impact on your own diabetes self-management?  
 
Things impacting your own diabetes 
self-management 
Best  
(pick only one) 
Worst 
 (pick only one) 
Access to healthy food ☐ ☐ 
Healthcare providers ☐ ☐ 
My ability to pay ☐ ☐ 
Local events ☐ ☐ 




Figure 4-2 Bayesian information criterion (BIC) from the latent class logit models 
with one to ten classes 
 
LCL: latent class logit;  
SLCL (worst): scale-adjusted latent class logit with different scale for worst choices;  
SLCL (worst+2): scale-adjusted latent class logit with different scale for worst choices 
and two scale classes for choice consistency;  
LCL_best: latent class logit with best choices;  
LCL_worst: latent class logit with worst choices; 





















Figure 4-3 Average conditional probability of each factor being chosen as best in a 


























































Figure 4-4 Average conditional probability of each factor being chosen as worst in a 


























































Figure 4-5 Conditional probability of the 5-category best-worst score for each object 
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Table 4-1 Prioritization factors included in the best worst scaling survey 
Local events  
Do your local events (e.g. cultural, community, or religious) 
impact your ability for diabetes self-management? 
Support from others 
Do you have enough support from friends, co-workers, support 
groups or others in your community?  
Access to healthy food 
Do you have regular access to healthy food that will support 
your ability for diabetes self-management? 
Healthcare providers 
Do your healthcare providers have a positive or negative impact 
on your ability to self-manage you diabetes? 
Physical environment 
Does the place/location where you live and work provide you 
with the resources to manage your diabetes? 
Staying motivated  
Do you usually have the self-control to make the best choices for 
managing your diabetes? 
My own knowledge 
Do you feel you know enough about diabetes to self-manage 
your diabetes? 
Family commitments 
Does your family have a positive or negative impact on your 
ability to self-manage your diabetes? 
Work commitments 
Does your work (or other responsibilities) affect your ability to 
self-manage your diabetes? 
My ability to pay 
Do you have enough money to successfully self-manage your 
diabetes? 
Other health conditions 
Do you have other health conditions (mental and physical) that 




Table 4-2 Sample characteristics 
 N Percent 
Demographic Characteristics 
Age (mean) 536 61.66 
Gender   
Male  285 0.53 
Female 251 0.47 
Race   
White 280 0.52 
Black 121 0.23 
Hispanic 116 0.22 
Other  19 0.03 
Education   
Less than high school 35 0.07 
High school 335 0.62 
Bachelor’s degree or higher 166 0.31 
Income   
< 25,000 133 .25 
25,000 – 50,000 150 .28 
50,000 – 74,999 110 .20 
≥ 75,000 143 .27 
Health-related Characteristics 
Years of diagnosis (mean) 530 11.17 
Self-Reported Health   
Excellent 25 .05 
Very good 141 .26 
Good 230 .43 
Fair 116 .22 
Poor 24 .04 
No. A1c measured in last 6 months   
None 41 .08 
1 time 244 .45 
> 2 times 239 .45 
Don’t know 11 .02 
Most recent A1c level   
≥ 7.0% 230 .43 
< 7.0% 212 .40 
Don’t know 89 .17 
Type of diabetes medicine used   
No prescription medicine 44 .08 
Only pills 325 .61 
Only injections/shots 39 .07 
Pills and injections/shots 127 .24 
No complications 315 .59 
No other chronic conditions 80 .15 
Personality Characteristics   
Agree or strongly agree with the following statement 
I’m always optimistic about my future 334 .62 
I have a lot of self-control 270 .50 
I’m actively working to improve my health 333 .62 
I consider myself a risk-taker 89 .17 
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Table 4-3 Multinomial logit regression of facilitator class membership on individual 
characteristics 
 Marginal Effect (SE) 















Age  0.005** (.002) -0.001   (.002) -0.002  (.002) -0.001  (.002) -0.001    (.002) 
Gender      
Male  Reference     
Female -0.069    (.046)  0.042   (.044)  0.059  (.045)  0.034  (.038) -0.065    (.035) 
Race      
White Reference     
Black -0.080    (.054) -0.058   (.046) -0.091* (.046)  0.102  (.059)  0.127*   (.056) 
Hispanic -0.170** (.056)  0.094   (.076)  0.014  (.060)  0.082  (.059) -0.019    (.055) 
Other  0.077    (.119) -0.033   (.086) -0.132  (.081) -0.088  (.054)  0.178    (.107) 
Education      
No high school Reference     
High school  0.019    (.096)  0.130*  (.057)  0.077  (.059) -0.159  (.092) -0.066    (.093) 
Bachelor+  0.014    (.104)  0.151*  (.072)  0.074  (.073) -0.094  (.100) -0.145    (.095) 
Income      
< 25,000 Reference     
25,000-49,999 -0.047    (.063) -0.054   (.065)  0.075  (.055)  0.030  (.053) -0.003    (.057) 
50,000-74,999  0.022    (.070) -0.096   (.065)  0.085  (.064)  0.059  (.063) -0.069    (.046) 
≥ 75,000 -0.047    (.066) -0.099   (.068)  0.064  (.064)  0.024  (.055)  0.057    (.059) 
Health Status      
Excellent Reference     
Very good -0.070    (.105)  0.120*  (.058) -0.093  (.105)  0.103  (.079) -0.059    (.100) 
Good -0.088    (.104)  0.180** (.054) -0.038  (.102)  0.025  (.076) -0.078    (.098) 
Fair  0.011    (.114)  0.173*  (.069) -0.107  (.108) -0.006  (.086) -0.071    (.102) 
Poor -0.240*   (.122)  0.180*  (.096) -0.004  (.138)  0.144  (.125) -0.081    (.121) 
No. HbA1c Test in past 6 months    
None  Reference     
1 or more  0.129    (.071)  0.096   (.058) -0.147  (.089)  0.013  (.081) -0.091    (.072) 
Don't know  0.122    (.149) -0.025   (.104)  0.252  (.164) -0.135  (.086) -0.213** (.067) 
Recent HbA1c Level     
> 7% Reference     
≤ 7% -0.025    (.049)  0.019   (.044)  0.065  (.046) -0.042  (.040) -0.017    (.033) 
Don't know -0.086    (.063)  0.022   (.066)  0.041  (.061) -0.012  (.069)  0.035    (.052) 
I have a lot of self-control     
Disagree Reference     
Agree -0.078    (.060) -0.010   (.052)  0.017  (.050)  0.118* (.052) -0.047    (.050) 
I consider myself a risk-taker     
Disagree Reference     




Table 4-4 Multinomial logit regression of barrier class membership on individual 
characteristics 
 Marginal Effect (SE) 















Age -0.002  (.003)  0.001     (.002)  0.002    (.002) -0.002 (.002)  0.000    (.002) 
Gender      
Male  Reference     
Female -0.014  (.051) -0.013     (.043)  0.042    (.040) -0.007 (.035) -0.008    (.028) 
Race      
White  Reference     
Black  0.039  (.065) -0.011     (.057) -0.059    (.055)  0.000 (.042)  0.032    (.040) 
Hispanic  0.138  (.086)  0.020     (.062) -0.085    (.065) -0.006 (.050) -0.066** (.023) 
Other  0.035  (.106) -0.193*** (.042) -0.039    (.078)  0.061 (.093)  0.137    (.073) 
Education      
No high school Reference     
High school  0.035  (.107) -0.118     (.099)  0.133*   (.065) -0.074 (.085)  0.023    (.048) 
Bachelor+  0.029  (.115) -0.075     (.112)  0.169*   (.075) -0.095 (.096) -0.028    (.050) 
Income      
< 25,000 Reference     
25,000-49,999 -0.053  (.072)  0.017     (.065)  0.117*   (.055) -0.025 (.054) -0.056    (.036) 
50,000-74,999  0.053  (.079) -0.074     (.067)  0.131*   (.060) -0.043 (.056) -0.067    (.040) 
≥ 75,000 -0.072  (.071) -0.126     (.067)  0.119*   (.062)  0.044 (.067)  0.034    (.045) 
Employment      
Employed Reference     
Unemployed -0.042  (.070)  0.050     (.065) -0.082    (.057)  0.037 (.054)  0.036    (.037) 
Retired -0.023  (.069) -0.066     (.054)  0.030    (.061)  0.029 (.056)  0.030    (.043) 
Health Status      
Excellent Reference     
Very Good  0.097  (.108) -0.007     (.095)  0.036    (.083)  0.123 (.064) -0.248*   (.111) 
Good  0.028  (.105)  0.027     (.092)  0.076    (.084)  0.087 (.059) -0.217*   (.106) 
Fair -0.033  (.114)  0.029     (.098)  0.239*   (.098)  0.003 (.061) -0.237*   (.112) 
Poor -0.162  (.131)  0.091     (.133)  0.261    (.155)  0.054 (.089) -0.244*   (.123) 
No. HbA1c tests in past 6 months    
None Reference     
1 or more  0.024  (.096) -0.028     (.084) -0.047    (.079)  0.051 (.050)  0.000    (.045) 
Don't know -0.020  (.162)  0.112     (.149) -0.054    (.145)  0.054 (.123) -0.092*   (.040) 
Recent HbA1c Level     
> 7.0% Reference     
≤ 7.0%  0.041  (.054) -0.045     (.046)  0.034    (.045)  0.026 (.040) -0.056*   (.024) 
Don't know  0.007  (.074) -0.087     (.053) -0.014    (.064) -0.030 (.044)  0.124*   (.059) 
I have a lot of self control     
Disagree Reference     
Agree  0.160* (.067) -0.052     (.061) -0.111    (.061)  0.023 (.049) -0.020    (.037) 
I consider myself a risk-taker     
Disagree Reference     
Agree  0.037  (.071)  0.085     (.066) -0.141** (.051) -0.002 (.056)  0.020    (.040) 
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Table 4-5 Multinomial logit regression of class membership from best-worst scores 
on individual characteristics 
 Marginal Effect (SE) 
 Class 1 Class 2 Class 3 Class 4 
Age -0.001 (.003) -0.001     (.002)  0.004    (.002) -0.003  (.003) 
Gender     
Male  Reference    
Female -0.001 (.047) -0.036     (.042) -0.001    (.046)  0.038  (.047) 
Race     
White Reference    
Black -0.006 (.060) -0.013     (.058)  0.000    (.055)  0.019  (.069) 
Hispanic  0.028 (.068)  0.050     (.068)  0.022    (.069) -0.100  (.066) 
Other -0.072 (.092)  0.082     (.106)  0.006    (.098) -0.016  (.114) 
Marital Status     
Married Reference    
Widowed/Divorced 
/Separated  0.056 (.059) -0.138**  (.049)  0.025    (.052)  0.056  (.060) 
Never married  0.117 (.081) -0.227*** (.048)  0.081    (.078)  0.029  (.075) 
Education     
No high school Reference    
High school -0.241* (.116)  0.234*** (.042) -0.025    (.097)  0.033  (.110) 
Bachelor+ -0.274* (.129)  0.219*** (.057)  0.086    (.106) -0.032  (.121) 
Income     
< 25,000 Reference    
25,000-49,999  0.009 (.068)  0.033     (.069) -0.051    (.061)  0.009  (.067) 
50,000-74,999 -0.056 (.075)  0.006     (.070)  0.085    (.073) -0.035  (.067) 
≥ 75,000 -0.098 (.079) -0.048     (.073) -0.015    (.070)  0.162* (.079) 
Employment     
Employed Reference    
Unemployed  0.058 (.068) -0.036     (.060)  0.007    (.067) -0.029  (.061) 
Retired -0.043 (.062)  0.019     (.065) -0.038    (.059)  0.062  (.071) 
Health Status     
Excellent Reference    
Very Good -0.026 (.110)  0.058     (.073) -0.021    (.097) -0.011  (.119) 
Good -0.057 (.108)  0.197**  (.072) -0.073    (.097) -0.067  (.119) 
Fair -0.057 (.116)  0.187*    (.086) -0.108    (.107) -0.022  (.132) 
Poor  0.020 (.147)  0.306*    (.130) -0.189    (.130) -0.138  (.144) 
No. HbA1c tests in past 6 months   
None Reference    
1 or more  -0.007 (.083)  0.072     (.077)  0.011    (.083) -0.076  (.088) 
Don't know  0.159 (.162) -0.119     (.099)  0.164    (.174) -0.204  (.130) 
Recent HbA1c Level    
> 7.0% Reference    
≤ 7.0% -0.104* (.048)  0.073     (.043)  0.058    (.049) -0.028  (.048) 
Don't know -0.107 (.069)  0.129     (.076)  0.010    (.060) -0.032  (.064) 
I have a lot of self-control    
Disagree Reference    
Agree  0.002 (.062) -0.031     (.057)  0.167** (.053) -0.139* (.066) 
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Table 4-6 Cross-tab between class membership from best-worst scores and class 
membership from best or worst choices 
  BW Score  
   Class 1 Class 2 Class 3 Class 4 Total 
Facilitato
r Classes 
Class 1  37 39 33 33 142 
Provider-driven 26.1% 27.5% 23.2% 23.2%  
Class 2  25 74 15 2 116 
Support-driven 21.6% 63.8% 12.9% 1.7%  
Class 3  29 18 36 31 114 
Health food-driven 25.4% 15.8% 31.6% 27.2%  
Class 4  55 0 40 10 105 
Motivation-driven 52.4% 0 38.1% 9.5%  
Class 5  6 7 7 39 59 
Affordability-driven 10.2% 11.9% 11.9% 66.1%  
Total 152 138 131 115 536 
  Class 1 Class 2 Class 3 Class 4 Total 
Barrier 
Classes  
Class 1  22 30 108 14 174 
Work-committed 12.6% 17.2% 62.1% 8.0%  
Class 2  94 28 9 0 131 
Affordability-
lacking 
71.8% 21.4% 6.9% 0  
Class 3  4 55 2 53 114 
Motivation-lacking 3.5% 48.2% 1.8% 46.5%  
Class 4  17 2 10 43 72 
Support-lacking 23.6% 2.8% 13.9% 59.7%  
Class 5  15 23 2 5 45 
Healthy food-
lacking 
33.3% 51.1% 4.4% 11.1%  








Chapter 5 Conclusion and Policy Implication 
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Stated-preference researchers have been increasingly using latent class analysis 
(LCA) to analyze preference heterogeneity in the health context in the past decade in a 
widening range of countries. Preferences have been assessed on a variety of topics, 
including medical treatments, preventive interventions, general health services, quality of 
life, provider job preference, and resource allocation. Patient preference is the focus in 
majority of the research. Several studies compared how preference varied from different 
perspectives. While most segmentation was performed to direct the development of 
tailored treatments, prevention programs, or personalized care in the past twenty years, 
results on preference heterogeneity have been increasingly used to inform policy since 
2010.  
Although the quality of LCA studies has been improving over time, there is still 
large variation in how the analysis is conducted. Many studies failed to justify the choice 
of sample size, model specification, model selection criteria, and individual covariates to 
include in the model, which seem to be largely determined by the software used for LCA. 
However, an analysis across the studies showed that the number of classes reported in the 
study was not correlated with stated-preference methods, segmentation methods, or 
model selection criteria, but only sample size. This could be because the number of 
classes identified in a study was indeed not subject to survey or segmentation methods, 
but given that 80% of the studies reported two to three classes, it is likely that most 
studies were underpowered to detect more classes. In addition, many studies limited the 
number of classes they report by considering the interpretation of the segments when 
selecting models, especially when information criteria or other statistical criteria failed to 
identify a practical amount of segments for implementation. Although policy and clinical 
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relevance is important, model fit should still be considered to ensure reliable estimates 
and accurate prediction.  
Latent class logit (LCL) is the most commonly used segmentation model for 
discrete choice data. It has been applied in preference data obtained from discrete choice 
experiment (DCE) and best-worst scaling (BWS), two most common stated-preference 
methods used in health according to the systematic review. However, both applications 
have limitations. In DCE, when there is substantial within-class preference heterogeneity 
or significant overlap between classes, LCL may over-fit the data and lead to too many 
classes that are difficult to incorporate in policy or clinical decision-making. As a 
remedy, random effects can be incorporated in LCL models. With more flexible model 
specification, random effect LCL (RELCL) is shown not only reducing the number of 
classes but also better capturing the complex and dispersed preference pattern among 
patients than LCL, leading to improved model fit and prediction accuracy. Given that 
healthcare regulatory and clinical decision-makers often prefer parsimonious results due 
to limited resources and capacity to accommodate too many preference types, researchers 
can consider using RELCL as a tool to generate more practical results to meet the 
specific needs.  
When LCL is applied to BWS data, information criteria also often fail to identify 
the best-fitted model and parsimonious segmentation results. This is because the utility 
parameter for each object in LCL is assumed to be constant across choices tasks and 
therefore sensitive to the full sequence of choices. When there are many choice tasks and 
large variation in choice sequence among respondents, there is significant variation in 
utility parameters. Segmentation based on a large set of utility parameters with 
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substantial variances can lead to a large number of classes. By relaxing the cross-task 
constant utility constraint, the standard LC model can dramatically reduce the number of 
classes and generate parsimonious segmentation results. Depending on the study 
objective, the standard LC model can either be applied to the best or worst choices, or to 
the best-worst scores. Overall, researchers should consider using flexible model 
specification for reliable and practical results to support policy and clinical decision-
making when analyzing BWS data.  
5.1 Policy and Clinical Implications  
In 2012, the President signed into law the Food and Drug Administration Safety 
and Innovation Act (FDASIA) of 2012, which reauthorized the Prescription Drug User 
Fee Act (PDUFA). Subsequent PDUFA amendments require the Food and Drug 
Administration (FDA) to develop and implement a structured approach to benefit-risk 
assessment in the new drug-approval process. In response to the amendments, the FDA’s 
Center for Drug Evaluation and Research (CEDR) established the Patient-Focused Drug 
Development initiative2, aiming to obtain patients’ perspective on disease conditions and 
treatments using a systematic approach. FDA launched the initiative in 2012 by 
announcing 20 disease areas to focus on during the first three years3. Public meetings 
were conducted among FDA review divisions, patient-advocacy communities, and other 
interested stakeholders to gather information on the challenges and possible barriers to 
treatment patients face in the selected disease areas to help inform drug-development and 
regulatory review processes.  
                                                        
2 Patient-Focused Drug Development. 
http://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm326192.htm. 
3 Prescription Drug User Fee Act Patient-Focused Drug Development; Announcement of Disease Areas for 
Meetings Conducted in Fiscal Years 2016–2017. http://www.gpo.gov/fdsys/pkg/FR-2015-07-02/pdf/2015-
16359.pdf 
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During the same year, the FDA Center for Devices and Radiological Health 
(CDRH) released guidance to clarify the principal benefit-risk factors that FDA considers 
during the reviews for premarket approval for medical devices (CDRH, 2012). In 
addition to description of benefits and risks, the guidance listed patient preference as an 
important factor to consider in regulatory reviews. It recognizes heterogeneity in risk 
tolerance and benefit-risk tradeoff among patients, and expresses the willingness to 
consider the whole spectrum of patient preferences and approve a medical device that 
demonstrates meaningful benefits even though its benefit-risk profile is only acceptable 
to a subset of risk-tolerant patients. A more recent guidance provides details on how 
patient preference information should be included in the applications (CDRH, 2015). 
Learning patient preference and preference heterogeneity will support these 
policy movements towards patient-centered regulatory decision-making and expand 
access to effective treatments for patients. Patients have unique perspectives about the 
benefits and risks of medical treatments. But in order to incorporate these views in 
regulatory decision-making, researchers should have reliable and accurate methods, tools, 
and approaches (Johnson et al, 2016). Stated-preference methods have been widely used 
in health to quantify patients’ opinions. Compared to qualitative approaches such as focus 
group interviews, they allow researchers to survey a larger sample of patients and study 
heterogeneity in preferences. As segmentation is an appealing approach to describe 
preference heterogeneity due to the straightforward interpretation and policy implication, 
its application in stated-preference studies in health is often unsatisfactory. We proposed 
alternative models in this dissertation to improve such application. Future researchers can 
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consider using these models to produce more reliable, accurate, and practical results to 
support regulatory decision-making.  
The diabetes case study demonstrated how these models could be used to support 
patient-centered drug development. Significant preference heterogeneity for diabetes 
medication was found among patients. While some patients focused on cost and 
effectiveness of the medicine when choosing treatment, others cared more about side 
effects and treatment burden. Such heterogeneity was not only associated with patients’ 
socio demographic characteristics, such as age and income, but also affected by their 
health status, current treatment, and even personality. To meet the various needs, FDA 
may consider approving more effective or cheaper medicines for people who are willing 
to take higher risk of side effects or greater treatment burden, and approving medicines 
with fewer side effects for those who want to avoid side effects even for a higher price. 
Patients should have access to both to choose from according to their preference.  
In addition to preference heterogeneity in treatment, barriers and facilitators for 
diabetes management also varied among patients, which can be explained by socio 
demographics, health status, and personality. Although healthcare providers and policy 
makers have been emphasizing expanding access to healthy food and holding local events 
to improve patients’ diabetes self-management, we found that access to healthcare, 
family and social support, work commitment and motivation had more significant impact 
on diabetes management. Expanding health insurance coverage to the uninsured or 
underinsured patients and enhancing work environment to facilitate disease management 
are more effective approaches that policy makers can take to improve health outcomes 
among diabetes patients. Healthcare providers can consider involving patients’ family 
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and other social groups during the treatment to support and motivate patients. A 
collaborative effort between regulators and providers to develop treatment plans that are 
tailored to meet individual needs is likely to improve treatment adherence and health 
outcomes.  
5.2 Limitations 
There are several limitations in the study. First, the datasets used in this 
dissertation are relatively small. There has not been recommendation on sample size 
calculation for LCA, because the calculation depends on the number of classes, 
difference in utility parameters between classes, and the class size, all of which is 
difficult to predict. Orme (2006) recommended a rule of thumb of 200 respondents per 
subgroup, but since LCA is probabilistic (i.e., each respondent has a probability of 
belonging to each class), 200 per subgroup may not be necessary. In addition, as the 
classes may not have equal share of the study sample, it is possible that some groups end 
up having fewer than 200 respondents. With 500 respondents, although our sample size is 
larger than majority of the segmentation studies in the literature, it still limited our ability 
to impose more flexible model specifications with more parameters. Future studies 
should use larger dataset to test the models we proposed in this dissertation.  
Second, the sample was not representative of the entire diabetes population. As 
discussed in the previous chapters, the study samples were more educated and had higher 
income on average than the general diabetes patient population. Although sampling 
weight was used to adjust standard errors and class distribution, the lower-income and 
less-educated patients’ preference and priority was underrepresented in the sample. This 
is particularly important when we study preference heterogeneity. Most studies in the 
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literature do not examine the representativeness of the sample. Researchers and decision-
makers therefore should be cautious about generalizing results to the entire study 
population or comparing across studies. Representative study sample should be 
emphasized for future stated-preference studies in health to better support policy.  
Third, the proposed models were only applied to preference data from patients 
with type 2 diabetes. Since diabetes is a prevalent chronic condition, diabetes patient 
group can be more diverse than other patient groups in terms of socio demographics, 
health status, experience, culture, and personalities. The diverse population 
characteristics can lead to more dispersed preference distribution that we may not see 
among patients with more acute or severe conditions. The proposed models can be tested 
among other patients groups in future research. A comparison of preference distribution 
between different patient groups can be beneficial.  
Fourth, we only used patients’ stated-preference data, the choices in which are 
likely to be different from the choices observed in reality. However, because stated-
preference methods measure patient preference in controlled laboratory environment and 
remove confounding from other factors, they better serve FDA’s goal of understanding 
patient perspectives on benefits and risks of medical treatments. Researchers could test 
the proposed models in revealed preference data, but the models should be adjusted to 
control for confounding from such factors as provider preference, choice context, and 
choice set.  
Finally, one weakness of testing models using empirical data is that the true 
preference parameters are unknown. We compared alternative models with different 
distribution assumptions and assessed their fit using information criteria, but we were 
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unable to examine how far the estimates from the best-fitted model were from patients’ 
true utility values. Researchers should use simulation to further evaluate the performance 
of the proposed models in this dissertation and assess the threshold for when the proposed 
models start to outperform the traditional ones.  
Despite the limitations, this dissertation overviews the application of LCA in 
stated-preference studies in health. It identifies the issues in the application and modifies 
the traditional segmentation models to better fit the complex preference data in health. By 
allowing more flexible model specifications, we provide stated-preference researchers a 
tool to generate parsimonious and practical results to serve regulatory decision-making 
purposes. This dissertation can serve as a methodological guide for researchers who are 
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